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 Abstract 
 
Metabolism regulates cell fate in lymphocytes and progenitor cells 
Radomir Kratchmarov 
 
Self-renewal mediates homeostasis across mammalian organ systems as the cellular 
components of mature tissues are continually replaced in the face of wear and tear, 
injury, infection, and malignancy. The hematopoietic and immune systems are crucial 
for organismal longevity and rely on the ability of progenitor cells to bifurcate in fate to 
produce mature terminally differentiated progeny while self-renewing to maintain more 
quiescent progenitors. Asymmetric cell division is associated with self-renewal of 
lymphocytes and hematopoietic progenitors, but the mechanisms underlying the cell 
biology of these processes remain incompletely understood. Here we show that 
metabolic signals in the form of differential anabolism and catabolism regulate 
asymmetric division and cell fate bifurcations. Key transcription factors, including TCF1 
and IRF4 in lymphocytes and IRF8 in hematopoietic progenitors, occupy regulatory 
nodes where signals associated with metabolism and traditional cell fate determinants 
converge. Notably, anabolic PI3K/mTOR signaling was required for terminal 
differentiation of both lymphocytes and hematopoietic progenitors through the regulation 
of a constellation of nutrient uptake, mitochondrial turnover, reactive oxygen species 
production, and autophagy. Further, we found that antigen receptor signaling in 
lymphocytes organizes a cell-intrinsic polarity pathway of asymmetric intracellular 
membrane trafficking that is regulated by PI3K activity and associated with terminal 
differentiation. These results support a model wherein cell fate bifurcations are 
organized by metabolic signaling at the population and subcellular level to ensure self-
renewal of progenitor and memory populations.  
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Organismal homeostasis is inherently linked to cellular turnover and pattern formation. 
Tissues continually replace their cellular components in the face of external stimuli, 
aging, and normal wear-and-tear. Stem and progenitor cells of the different organ 
systems differentiate to populate the mature cell compartment and maintain organ 
function during turnover. However, this differentiation is balanced with self-renewal to 
maintain a pool of multi-potent cells that retain the capacity to proliferate and replenish 
the mature cells. Self-renewal is therefore critical for maintenance of dynamic tissues 
and organs over time, including the hematopoietic and immune systems.  
Hematopoietic progenitor cells differentiate and diverge in fate to populate the 
mature blood lineages during pattern formation, normal organismal homeostasis, and 
infection/cancer. Similarly, following clonal selection, naïve lymphocytes differentiate 
into diverse effector cells, e.g T follicular helper cells and T helper cells, or germinal 
center B cells and plasmablasts, as well as quiescent memory cells. To prevent 
exhaustion and collapse of these systems in the face of a continual need to create 
mature, terminal cells, mechanisms have evolved to balance these differentiation 
programs. 
While it is well-established that individual clones of the hematopoietic and 
immune systems generate intraclonal diversity during differentiation, the mechanisms 
underlying these cell fate bifurcations are controversial, with alternate stochastic and 
deterministic models having been proposed (reviewed in (Reiner and Adams, 2014)). 
Further, development and differentiation of hematopoietic progenitors has also 
remained controversial, with models supporting either step-wise bifurcative 
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developmental trees or stochasticity and lineage biasing (Hoppe et al., 2016; Naik et al., 
2013; Pei et al., 2017). 
Under stochastic models, activated clones proliferate and generate a 
heterogeneous population of cells with differential biases toward one fate; differentiation 
then proceeds along a linear path toward a single fate (Buchholz et al., 2013; Duffy et 
al., 2012; Gerlach et al., 2013). Averaging of these linear paths across the total 
population of clones would then produce the heterogeneous response observed in vivo. 
For B and T cells, these fate differences have been postulated to involve TCR/BCR 
signal strength (Taylor et al., 2015; Tubo et al., 2013). These studies have been based 
in part on a substantial body of mathematical modeling owing to difficulties with 
barcoding techniques and tracking of single cell progeny in vivo.  
Asymmetric cell division has been described across numerous metazoan species 
and enables a cell to generate divergent progeny that either remain quiescent or 
undergo terminal differentiation (Morrison and Kimble, 2006). Deterministic fate maps 
involving asymmetric division describe the developmental pathways in many model 
systems including C. elegans. Evidence for asymmetric division in the hematopoietic 
and immune systems has been provided in infection, malignancy, and at steady state 
(Chang et al., 2007; Dey-Guha et al., 2011; Pham et al., 2015; Ting et al., 2012; Wu et 
al., 2007; Zimdahl et al., 2014). T cells undergoing the first division in vitro and in vivo 
can divide asymmetrically, apportioning unequal amounts of receptors, transporters, 
and adhesion molecules between the first two daughter cells (Chang et al., 2007; 2011; 
Pollizzi et al., 2016; Verbist et al., 2016). These instances of asymmetric division are 
organized by external polarity cues in the form of contact with an antigen presenting cell 
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and were postulated to impart differential capacities on the proximal and distal daughter 
cells to become effector and memory cells respectively. Further, cancer stem-like cells 
and hematopoietic progenitors divide asymmetrically depending on extrinsic signaling 
factors as well as intrinsic signaling (Dey-Guha et al., 2011; Habib et al., 2013; Wu et 
al., 2007). 
While asymmetric division in mammalian lymphocytes and hematopoietic cells 
has been described by many groups, its requirement for cell fate and development has 
remained enigmatic. One candidate mechanism, the polarity network family of proteins 
(PAR), was first described in C. elegans and constitutes an ancient group of symmetry-
breaking cytosolic proteins that have been implicated in asymmetric division and pattern 
formation of lower-order metazoa (Goldstein and Macara, 2007). However, initial work 
in mammalian systems has yielded only partial or incompletely penetrant phenotypes in 
both hematopoietic cells and lymphocytes (Hawkins et al., 2013; Metz et al., 2015; 
2016; Sengupta et al., 2011). Thus, cell intrinsic mechanisms that organize cellular 
polarity and symmetry-breaking in higher-order mammals remain unclear. 
Emerging evidence implicates the metabolic state of hematopoietic cells and 
lymphocytes as a determinant of cell fate (Chandel et al., 2016; Ito and Ito, 2016). Naive 
and quiescent memory lymphocytes employ a program of catabolic metabolism, 
including mitochondrial oxidative phosphorylation (Ox-Phos), fatty acid b-oxidation, and 
autophagy, for homeostasis and self-renewal. In contrast, activation and proliferation of 
effector T cells and plasmablasts requires anabolic metabolism, including 
PI3K/Akt/mTOR activity, aerobic glycolysis, and induction of the Warburg effect – the 
preferential use of aerobic glycolysis despite oxygen abundance (Buck et al., 2017). 
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Phospholipid signaling activated by growth factor receptor tyrosine kinases and PI3K 
has also been implicated in polarity and immune synapse formation (Le Floc'h et al., 
2013).  
This thesis characterizes the role of asymmetric metabolic signaling in cell fate 
decisions for model lymphocyte systems as well as a hematopoietic progenitor 
population. The results described herein are consistent with a model where PI3K activity 
organizes a polarity pathway involving membrane and organelle traffic that regulates a 
key node governing transcriptional and metabolic control of cell fate decisions.  
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Chapter 1: Effector Th1 CD4+ T cell differentiation mediated by PI3K 
 
Portions of this Chapter have been adapted from the following manuscripts: 
 
Nish SA, Zens K, Kratchmarov R, Lin WH, Adams WC, Chen YH, Yen B, Rothman NJ, 
Bhandoola A, Xue HH, Farber D, Reiner SL. (2016). CD4+ T Cell Effector Commitment 
Coupled to Self-renewal by Asymmetric Cell Divisions. Journal of Experimental 
Medicine. 214: 1-10. doi.org/10.1084/jem.20161046.  
 
Kratchmarov R, Nish SA, Lin WHW, Adams WC, Chen YH, Yen B, Rothman NJ, Klein 
U, and Reiner SL. (2017). IRF4 Couples Anabolic Metabolism to Th1 Cell Fate 









During infection, activated CD4+ T cell clones proliferate and diverge in fate to produce 
terminally differentiated effector cells as well as self-renewing memory cells that 
respond to future infections. Cellular metabolism can determine a lymphocyte's fate and 
function. In this study, we characterized the role of PI3K signaling in driving terminal 
differentiation of Th1 type CD4+ T cells. PI3K was required for terminal Th1 
differentiation, as indicated by repression of the transcription factor TCF1, induction of 
Blimp1 expression, and cytokine production. Terminal differentiation was associated 
with elevated mTOR activity. Furthermore, we show that IRF4, a transcription factor that 
mediates metabolic reprograming, promotes Th1 differentiation and anabolic 
metabolism. IRF4-deficient CD4+ T cells exhibited defective repression of TCF1 and 
impaired induction of Th1-associated markers including CD25 and T-bet, a master 
regulator of Th1 differentiation. IRF4-deficient CD4+ T cells also underwent a shift 
toward catabolic metabolism, with reduced PI3K/mTOR activation, deficient nutrient 
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uptake, and increased mitochondrial clearance. Taken together, these results indicate 
that PI3K and IRF4 are essential for the anabolic metabolism that directs determined 
Th1 differentiation. Our findings support a model wherein certain key transcription 









































Following TCR stimulation, naïve CD4+ T cells undergo clonal expansion and 
differentiate into distinct helper T cell subsets as well as long-lived memory cells that 
mount responses upon re-exposure to the pathogen. This heterogeneity in cell fate is 
essential for both combating current pathogens and preserving future immune function 
for the life of the organism. Memory T cells are found in distinct subsets based on 
distinct effector function and homing capacity (Masopust et al., 2001; Reinhardt et al., 
2001; Sallusto et al., 2004). Notably, these distinct subsets exhibit significant clonal 
overlap, indicative of a common naïve cell ancestor (Becattini et al., 2015).  
Different cytokines, including IL-4, IL-12, and IL-17, modulate effector cell 
differentiation to tailor the response to a given microbial pathogen. The Th1 subset is 
defined by expression of the lineage-determining transcription factor T-bet and the 
capacity to secrete effector molecules including IFN-γ and TNF-a (Zhu et al., 2010). 
Different transcription factors control the differentiation of CD4+ subsets, and IRF4 is 
important for Th2, Th9, Th17, Tfh, and Treg CD4+ responses (Bollig et al., 2012; Brüstle 
et al., 2007; Staudt et al., 2010; Tominaga et al., 2003; Zheng et al., 2009). The role of 
IRF4 in Th1 CD4+ differentiation is less clear (Lohoff et al., 2004; 2002; Tominaga et al., 
2003), though recent work indicates a role for IRF4 in Th1 responses both in vitro and in 
vivo (Mahnke et al., 2016). IRF4 is also critical for effector CD8+ T cell differentiation 
where it modules metabolic pathways (Man et al., 2013; Yao et al., 2013).  
Studies in both CD4+ and CD8+ T cells indicate that IRF4 functions as a 
regulator of the metabolic reprograming necessary for effector T cell function (Huber 
and Lohoff, 2014). Activated CD4+ T cells upregulate biosynthetic and bioenergetic 
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pathways necessary for proliferation, cytokine production, and migration (Pollizzi and 
Powell, 2014). Terminally differentiated Th1 CD4+ T cells have increased anabolic 
demands and preferentially employ aerobic glycolysis, as this subset proliferates 
extensively and engages lipid biosynthesis and cytokine production (Gerriets et al., 
2015; Michalek et al., 2011). This anabolic program is mediated primarily by the kinases 
PI3K and mammalian target of rapamycin (mTOR). Conversely, memory CD4+ and 
CD8+ T cells as well as Treg cells are primarily catabolic and rely on lipid oxidation and 
mitochondrial oxidative phosphorylation for ATP production (O'Sullivan et al., 2014; 
Pearce et al., 2009; van der Windt et al., 2013). The efficient induction of these anabolic 
and catabolic metabolic programs are critical for CD4+ T cell fate determination. 
Anabolic signaling itself directs the terminal differentiation and loss of self-renewal 
capacity in CD8+ T cells as well as B lymphocytes, likely through regulation of key 
transcription factors, such as FOXO1, that control both gene expression networks and 
cellular metabolic profiles (Lin et al., 2015).  
It has become increasingly apparent that metabolic signals are critical for 
directing the fate of lymphocytes. Fate-determining transcription factor expression can 
both regulate and receive input from the cellular metabolic state. To further understand 
how transcription factor expression is coupled to metabolic reprograming for cell fate 
determination, we explored whether PI3K signaling coordinately regulates TCF1 and 






PI3K signaling drives mTOR activation, TCF1 silencing, and Th1 cell 
differentiation 
Cytokine receptor binding interfaces with intracellular signaling networks. Previous work 
indicates that IL-2 may drive the down-regulation of the transcription factor TCF1 in 
CD4+ T cells, a transcriptional change associated with terminal effector cell 
differentiation (Wu et al., 2015). To determine the role for Th1-inducing cytokines in 
mediating TCF1-downregulation, we activated naïve CD4+ T cells with plate-bound anti-
CD3 and anti-CD28 in the presence of either IL-2 or IL-12 (Figure 1.1A). We found that 
both cytokines could independently drive TCF1 repression in the context of TCR 
stimulation, suggesting that cytokine signals can initiate terminal differentiation. 
Interestingly, this repression was dependent on intact PI3K signaling as treatment with 
the small molecule LY294002, a pan PI3K inhibitor, resulted in maintenance of TCF1 
expression despite IL-2/IL-12 stimulation. 
PI3K/mTOR activity is important for driving repression of TCF1 in CD8+ T cells 
and Pax5 in B cells (Lin et al., 2015), and is induced by IL-2 signaling (Ray et al., 2015). 
We found that inhibition of PI3K in the context of TCR stimulation prevented repression 
of TCF1, across cell divisions as proliferating cells remained largely TCF1-high (Figure 
1.1B). Th1 differentiation was also impaired in the context of PI3K inhibition, as 
activated cells failed to upregulated the cytokine IFN-g  and cytolytic granule component 
GranzymeB (Figure 1.1B). Moreover, PI3K inhibition decreased cellular proliferation 
following TCR stimulation and abrogated Blimp-1 induction, a key regulator of terminal 
differentiation (Crotty et al., 2010) (Figure 1.1C). Finally, inhibition of PI3K decreased 
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mTOR activity in proliferating cells, as determined by phosphorylation of the ribosomal 
subunit S6, confirming that increased anabolic signaling accompanies proliferation and 
terminal differentiation (Figure 1.1D). 
  
Figure 1.1. PI3K signaling driving TCF1 repression and Th1 effector 
differentiation. (A) TCF1 expression in CD4+ T cells stimulated for 5 d with anti-
CD3/CD28 in the presence of IL-2 or IL-12, without or with 5 μM PI3K inhibitor. 
Results are representative of at least three independent expreiments. (B) CPD 
versus TCF1, granzyme B (GzmB), and IFN-γ in CD4+ T cells stimulated for 5 d in 
Th1 cell–inducing conditions (IL-2 and IL-12) with or without PI3K inhibitor. Plots are 
representative of 3 or more independent experiments. (C) CPD versus Blimp-1–YFP 
expression in CD4+ T cells stimulated with or without PI3K inhibitor. Data are 
representative of three independent experiments. (D) CPD versus phospho-S6 (p-




Impaired Th1 differentiation in IRF4-KO CD4+ T cells 
IRF4 is thought to function downstream of PI3K/mTOR activation in activated T cells to 
direct metabolic reprograming for terminal differentiation (Yao et al., 2013). To explore 
the role of IRF4 in Th1-type CD4+ T cell responses, we first determined whether Th1 
effector cell differentiation required IRF4 expression. Naïve wild-type (WT) or IRF4-KO 
CD4+ T cells were labeled with a proliferation dye and TCR-stimulated under Th1-
skewing conditions (IL-2 / IL-12) in vitro. We then assayed cytokine production and 
cytotoxicity by flow cytometry following PMA/ionomycin stimulation to determine 
whether IRF4-KO cells were functional deficient (Figure 1.2A). Indeed, compared to WT 
cells lower percentages of IRF4-KO CD4+ T cells produced IFN-g, granzyme B, and 
TNF-α, indicating decreased effector function. Next, the expression of key transcription 
factors was assayed by flow cytometry after 4 days of culture. After several (3-4) 
divisions, two populations marked by differential (high / low) TCF1 expression emerged 
(Figure 1.2B). TCF1-high cells have Tfh and memory developmental potential, while 
TCF1-low cells undergo irreversible Th1-type terminal differentiation (Choi et al., 2015; 
Nish et al., 2017b; Wu et al., 2015; Xu et al., 2015b). Differentiation of the TCF1-low 
effector cell subset was decreased in IRF4-KO CD4+ T cell cultures (Figure 1.2B). 
Concurrently, expression of the Th1-master regulator T-bet as well as the high affinity 
IL-2 receptor CD25, a marker of activation, was also decreased (Figure 1.2B). 
Expression of CD62L, a chemokine receptor important for lymphoid tissue homing, was 
increased on IRF4-KO CD4+ T cells, further indicating decreased terminal differentiation 
(Figure 1.2B). Transduction of IRF4-deficient cells with T-bet-GFP retrovirus failed to 
rescue defects in TCF1 silencing and cytokine induction (Figure 1.2B). These results, 
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together with recent studies of IRF4 deficient cells using Listeria infection (Mahnke et 
al., 2016), suggest that IRF4 is required for the induction of optimal Th1 differentiation. 
The inability of T-bet overexpression to rescue terminal Th1 differentiation further 




















Figure 1.2. IRF4 is required for efficient Th1 CD4+ effector cell differentiation.
(A) CD4+ T cells labeled with CPD, stimulated with anti-CD3/CD28 + IL-2/IL-12, 
and re-stimulated with PMA/ionomycin on day 4. Representative FACS plots of 
indicated protein versus CPD (left panels). Quantification of the percent positive 
population in WT and IRF4-KO CD4+ T cells (right panels). (B) Representative 
FACS plots of TCF1 expression versus CPD in Th1-inducing conditions (top left 
and middle panels). Quantification of TCF1-low population in WT and IRF4-KO 
CD4+ T cells (top right panel). Representative histograms of T-bet, CD25, and 
CD62L expression (middle row). Quantification of protein expression in WT and 
IRF4-KO CD4+ T cells (bottom row). (C) Increased T-bet protein expression in WT 
and IRF4-KO CD4+ T cells following transduction with T-bet–GFP retrovirus (left 
panels). Expression of TCF1 (upper right panels) and TNF-! (lower right panels) by 
CD4+ T cells transduced (GFP+) or untransduced (GFP-) with T-bet–GFP 
retrovirus, at day 4 post-activation. Plots are representative of three independent 
experiments. * p<0.05 ** p <0.01 Paired t test. 
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Deficient anabolic signaling following TCR stimulation in IRF4KO CD4+ T cells 
Terminally differentiated effector CD4+ T cells require metabolic reprogramming to 
promote efficient effector function (Gerriets et al., 2015; Macintyre et al., 2014; Michalek 
et al., 2011). As IRF4 is important for effector CD8+ T cell anabolic pathways, we 
sought to determine the role of IRF4 in CD4+ T cell metabolism. TCR stimulation of 
CD4+ T cells induced robust PI3K/mTOR activation, indicated by phosphorylation of 
ribosomal subunit S6 (Figure 1.3A). Notably, IRF4-KO CD4+ T cells had decreased 
PI3K/mTOR activity, indicating that IRF4 is important for sustained PI3K signaling 
following TCR stimulation (Figure 1.3A). Deficient mTOR activation was evident in both 
early and late division cells and maintained throughout the duration of the experiment, 
suggesting that IRF4 plays a primary role in supporting PI3K/mTOR activation. Despite 
the impairment in phosphorylation of S6, levels of FoxO1 phosphorylation (another 
target of PI3K signaling) appeared normal in IRF4-deficient cells (Figure 1.3A), which is 
consistent with the ability of IRF4-deficient B cells to undergo inducible nuclear 
displacement of FoxO1 (Lin et al., 2015). While initial CD28 co-receptor stimulation 
directly induces PI3K activation (Powell et al., 1999), these results indicate that 
downstream transcription factors, including IRF4, are critical for maintaining anabolic 
kinase activity. 
T cell subsets with self-renewal capacity preferentially employ mitochondrial 
oxidative metabolism and have elevated catabolic signaling mediated by AMPK (Pearce 
et al., 2009). Furthermore, autophagy as well as mitophagy, the selective clearance of 
damaged mitochondria, are critical for memory T cell formation (Adams et al., 2016; Xu 
et al., 2014). This constellation of catabolic processes opposes terminal effector cell 
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differentiation (Adams et al., 2016). As IRF4-KO CD4+ T cells have decreased anabolic 
activity following TCR stimulation and decreased terminal differentiation, we sought to 
determine if increased catabolic signaling would be apparent in an in vitro assay of 
autophagy/mitophagy (Adams et al., 2016). We found that the cellular progeny of IRF4-
deficient cells exhibited enhanced clearance of aged mitochondria (Figure 1.3B), an 
index of catabolic mitophagy, which may predict a diminished likelihood of 
differentiation. Differences in the levels of aged mitochondria were evident beginning at 
the second division and persisted throughout later divisions (Figure 1.3B), further 
suggesting a primary role for IRF4 in sustaining nutritive signaling. Despite enhanced 
mitochondrial elimination, proliferating IRF4-deficient CD4+ T cells also had lower total 













Figure 1.3. IRF4 is required for anabolic induction of CD4+ T cells.
17
Figure 1.3. IRF4 is required for anabolic induction of CD4+ T cells.
(A) CD4+ T cells analyzed by phospho-flow cytometry for mTOR activity (pS6) 
(upper left and middle left panels). FACS plot statistic indicates mean 
fluorescence intensity (MFI) of phospho-S6. Quantification of phospho-S6 
levels (upper middle right panel). MFI of phospho-S6 at the indicated cell 
divisions (upper right panel). Error bars denote SEM. Representative 
histogram of p-FoxO1 levels in WT and IRF4-KO CD4+ T cells (lower left 
panel). Quantification of phospho-FoxO1 MFI (lower right panel). (B) WT and 
IRF4-KO CD4+ T cells pulse-labeled with CPD and MitoTracker Green, 
followed by TCR stimulation and flow cytometry analysis after 66 h (upper left 
and middle left panels). MitoTracker fluorescence (y-axis) decreases with each 
cell division (x-axis) as the pulse-labeled mitochondria age and are passively 
apportioned, as well as actively cleared by mitophagy. Frequency statistic 
indicates the percentage of cells in the MitoTracker-low trapezoidal gate. 
Quantification of the frequency of cells in the MitoTracker-low gate (upper 
middle right panel). MFI of pulsed MitoTracker fluorescence at the indicated 
cell divisions (upper right panel). Error bars denote SEM. Lower: 
Representative histograms of total mitochondrial content measured by 
MitoTracker Red, and mitochondrial membrane potential measured by TMRE. 
Quantification of MitoTracker Red MFI (lower middle left panel) Quantification 
of TMRE MFI (lower right panel). (C) Representative line graphs of CD4+ T 
cells labeled with CPD, stimulated in Th1 conditions, and analyzed by flow 
cytometry on day 4 of culture for forward scatter (FSC; cell size), expression of 
the indicated nutrient transporters (CD98 and Glut1), and glucose uptake (2-
NBDG) (upper panels). Quantification of the indicated flow cytometry 
parameters for WT and IRF4-KO CD4+ T cells (lower panels). * p<0.05, ** 
p<0.01. n.s. not significant. Paired t test.
18
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T cell activation induces an anabolic program of cell growth that depends on 
nutrient uptake. IRF4 mediates this metabolic reprogramming in CD8+ T cells, including 
anabolic nutrient transporter expression (Man et al., 2013). Following TCR stimulation, 
WT CD4+ T cells proliferated and increased cell size, indicative of blasting and anabolic 
signaling; however, IRF4-KO CD4+ T cells showed decreased blasting potential as 
indicated by forward scatter measurements (Figure 1.3C). In WT cells, Glut1, the 
primary inducible glucose transporter for CD4+ T cells, and CD98, an amino acid 
transporter, were both upregulated following TCR stimulation (Macintyre et al., 2014; 
Sinclair et al., 2013). However, Glut1 and CD98 expression was substantially decreased 
on IRF4-KO CD4+ T cells compared to WT (Figure 1.3C). We then assessed glucose 
uptake using the fluorescent glucose analog 2-NBDG (Figure 1.3C). Activated, 
proliferating CD4+ T cells imported more 2-NBDG than undivided cells for both WT and 
knockout cells. However, IRF4-KO CD4+ T cells showed a severe deficit in 2-NBDG 
uptake compared to WT cells. These results indicate that IRF4 is required for 
upregulation of nutrient transporters in CD4+ T cells during Th1 differentiation and 
suggest that defects in anabolism underlie the deficient terminal differentiation of Th1 









The emerging role of fate-determining transcription factors as regulators of selective 
metabolism constitutes a mechanism that may link bioenergetics and cell fate. Cell fate 
decisions in lymphocytes require the coordination of transcription factor networks with 
metabolic state. Our results indicate that PI3K and IRF4 occupy a key node in CD4+ T 
cell differentiation with the bifunctional capacity to both regulate expression of canonical 
Th1 transcription factors/receptors and modulate metabolic pathways. The coordinated 
activity of IRF4 in these spheres allows for the coupling of metabolic state to gene 
expression networks necessary for cell fate bifurcation. 
It was previously shown that IRF4 acts downstream of mTOR signaling in T cells 
(Yao et al., 2013). Our current results indicate that sustained mTOR activation itself also 
requires IRF4 function, consistent with a feed-forward, feed-back relationship that 
characterizes bistable systems. As such, perturbations of either upstream signaling or 
downstream processes of anabolism can skew the cellular metabolic profile. By 
licensing upstream nutritive signaling, nutrient uptake and utilization, and rewiring the 
transcriptional circuitry of cell fate, IRF4 couples metabolic and lineage choice. 
Mitochondrial biogenesis and fusion, which accompanies the autophagy of older 
mitochondria in physiological memory T cells, is essential for optimal oxidative 
metabolism and T cell memory (Buck et al., 2016). We found that IRF4-deficient cells 
exhibit a reduction in total mitochondrial content and mitochondrial membrane potential, 
despite enhanced mitochondrial turnover, suggesting that the severity of nutrient 
deprivation in the absence of IRF4 may prevent basal biogenesis of new mitochondria 
to offset the elimination of aged organelles. The resultant defects in mitochondrial 
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function would therefore be consistent with recent findings that oxidative metabolism is 
reduced in IRF4-deficient CD4+ T cells (Mahnke et al., 2016). Defective oxygen 
consumption of IRF4-deficient CD4+ T cells might therefore reflect severe catabolic 
metabolism rather than a role for IRF4 in mitochondrial biogenesis directly. 
Our results suggest that IRF4 does not direct two parallel but unrelated 
processes, i.e. Th1 gene induction and anabolic metabolism. Instead, defective 
anabolism in IRF4-deficient cells is analogous to glucose scarcity, which is directly 
responsible for defective Th1 differentiation and function (Gerriets et al., 2015; Michalek 
et al., 2011). Anabolic metabolism, mediated in part by IRF4, could drive Th1 
differentiation through its ability to support silencing of TCF1, a negative regulator of T-
bet induction (Choi et al., 2015; Wu et al., 2015). It remains unclear whether IRF4 and 
anabolic signaling mediate silencing of TCF1 solely through Akt-mediated inactivation of 
FoxO1, or if other gene regulatory mechanisms are involved. Taken together, this study 
demonstrates that PI3K signaling and IRF4 expression are required for efficient TCF1 
repression, via an anabolic signaling mechanism which balances the opposing cell fates 


















Mice and in vitro Th1 culture 
Wild type C57BL/6 and IRF4 KO (Klein et al., 2006) littermate mice served as sources 
of CD4+ T cells. Both male and female mice were used at age 8-10 weeks, and mice 
were housed in specific-pathogen-free conditions. All experiments were conducted in 
accordance with National Institutes of Health and Columbia University Institutional 
Animal Care and Use Committee guidelines. All efforts were made to minimize animal 
suffering and the number of animals used. Naïve CD4+ T cells were purified from 
spleens by magnetic cell separation (Miltenyi Biotech) and subsequently labeled with 
the cell proliferation dye (CPD) Cell Trace Violet (Thermo Fisher). 5x105 cells were 
seeded in 48-well tissue culture plates pre-coated with anti-CD3 (1ug/ml) and anti-CD28 
(1ug/mL) in Iscoves Modified Eagle Medium (Corning) supplemented with 10% FBS, IL-
2 (20 IU/ml), and IL-12 (10 ng/ml). For experiments with retroviral expression of Tbet-
GFP, cells were activated for at least 36 hours before spin infection, as previously 
described (can use the Adams citation). Following spin infection, cells were returned to 
the original culture media and cultured for an additional 48 hours before flow cytometric 
analysis.   
 
Flow cytometry 
Staining for flow cytometry analysis was performed as described (Lin et al., 2015). For 
phospho-flow cytometry, samples were first fixed with 4% paraformaldehyde for 15 
minutes followed by permeablization with ice-cold methanol for 5 minutes before 
antibody staining. Cytokine production was assayed following PMA (50ng/mL) and 
ionomycin (1ug/mL) re-stimulation for 4 hours. Antibodies used in this study include 
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CD25 (PC61; Biolegend), CD62L (MEL-14; BD Biosciences), CD98 (Rl388; Biolegend), 
anti-Glut1 (EPR3915; Abcam), T-bet (4B10; Biolegend), TCF1 (C63D9; Cell Signaling 
Technology), Phospho-S6 (S235/236; Cell Signaling Technology), GranzymeB (GB11, 
Biolegend), IFN-γ (XMG1.2, BD Biosciences), TNF-α (MPG-XT22, BD Biosciences), 
and goat anti-rabbit AlexaFluor 647 secondary (Thermo Fischer). Flow cytometry 
samples were acquired on a BD LSRII or BD Fortessa, and analysis was performed 
with FlowJo software (Treestar, San Carlos, CA). Glucose uptake following TCR 
stimulation was measured by incubating cells in 2-NBDG (Cayman; 100 μM) for 45 
minutes at 37 °C in glucose free RPMI supplemented with 10% dialyzed FBS. 
Mitoclearance was assessed by labeling naïve CD4+ T cells with Mitotracker Green 
(Thermo Fisher; 200nM per 1x10^6 cells) followed by two washes with complete media. 
Cells were then labeled with Cell Trace Violet and activated in Th1-inducing conditions. 
Clearance of mitochondrial fluorescence represents the sum of passive dilution during 
cell division plus active destruction through autophagy. Total mitochondrial mass and 
mitochondrial membrane potential were determined by labeling cells with Mitotracker 




Statistical analyses were performed using GraphPad Prism (version 6). P-values and 





Chapter 2: Asymmetric metabolic signaling regulates autophagy and 
mitochondrial stasis to determine lymphocyte cell fate 
 
Portions of this Chapter have been adapted from the following manuscript: 
 
Adams WC*, Chen YH*, Kratchmarov R*, Yen B, Nish SA, Lin WH, Rothman NJ, 
Luchsinger L, Klein U, Busslinger M, Rathmell JC, Snoeck HW, and Reiner SL. (2016). 
Anabolism-associated Mitochondrial Stasis Driving Lymphocyte Differentiation over 
Self-renewal. Cell Reports. 17: 3142–3152. doi:10.1016/j.celrep.2016.11.065. 
 







The mechanisms that orchestrate divergent cell fate amongst the cellular progeny of 
activated lymphocyte clones remain controversial. Recently, we showed that 
metabolic signals can direct the acquisition of effector versus memory fates in B and T 
cells, but the underlying cellular biology of this process has not been fully explored. To 
dissect the subcellular pathways involved, we assessed the role of mitochondrial 
turnover and autophagy, two key metabolic signaling nodes, in lymphocyte 
differentiation. Pharmacological or genetic perturbation of Drp1, a protein required for 
mitochondrial fission and mitophagy, resulted in increased terminal effector 
differentiation of both B and T cells with a concomitant increase in production of 
mitochondrial reactive oxygen species. Further, we observed unequal elimination of 
aged mitochondria between differentiating and self-renewing lymphocytes, at both the 
population and clonal level. Asymmetric elimination correlated with asymmetric 
autophagy at the single cell level, as well as effector versus memory cell fate in vivo. 
Additionally, we show that PI3K activity is required for mediating differential metabolic 
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signals at the subcellular level, in part through regulation of asymmetric 
autophagosome localization. These results suggest that asymmetric PI3K signals 
affect key subcellular organelles and their associated metabolic pathways to mediate 





Adaptive immunity involves the clonal selection of B and T lymphocytes wherein 
activated progenitor cells differentiate to produce functionally distinct progeny. The 
differentiation pattern of a naïve lymphocyte involves PI3K-driven changes in 
transcription factor expression and the development of both effector and memory cells, 
which uniquely retain the ability to self-renew. The process of lymphocyte differentiation 
is inherently linked to cell division, and asymmetric cell division offers a mechanism by 
which one cell may generate divergent progeny (Morrison and Kimble, 2006). Daughter 
cells of activated, dividing clones may self-renew due to unequal transmission of PI3K 
signaling (Lin et al., 2015). In both B cells and T cells, this divergence in cell fate occurs 
after several rounds of cell division. Activated progenitors that have undergone several 
divisions can give rise to asymmetric daughter cells, with unequal anabolic PI3K/mTOR 
activation and asymmetric inactivation of the transcription factor FOXO1 (Lin et al., 
2015). As such, the balance of cellular anabolism and catabolism is coupled to the 
transcriptional control of lymphocyte differentiation. 
Metabolic signals from the kinases PI3K/mTOR and AMPK reciprocally regulate 
nutrient uptake and autophagy, the catabolic process of cellular self-digestion that 
mediates proteostasis and digestion of macromolecules (Green et al., 2011). 
PI3K/mTOR activity represses autophagy while promoting anabolic pathways, including 
glycolysis and biosynthesis. Conversely, AMPK induces autophagy and inhibits mTOR 
(Gwinn et al., 2008; Inoki et al., 2003). Both memory B and T cells require autophagy for 
their formation and/or survival (Chen et al., 2014; Xu et al., 2014). 
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Cellular metabolism and metabolic signaling converges on mitochondria. As 
such, mitochondrial content and quality control is critical for both cellular metabolism 
and intracellular signaling pathways (Chandel, 2015). Mitochondrial mass and reactive 
oxygen species (mROS) production modulate hematopoietic cell fate (Owusu-Ansah 
and Banerjee, 2009) and direct activated B cells toward plasmablast or germinal center 
fate (Jang et al., 2015). mROS themselves can increase PI3K signaling and thus alter 
cell fate (Chen et al., 2008; Yalcin et al., 2010) while also being implicated in effector T 
cell differentiation (Sena et al., 2013) and NK cell memory formation (O'Sullivan et al., 
2015). Mitochondrial turnover in the form of fission, fusion, and mitophagy, is critical for 
maintaining a functional pool of healthy organelles (Mishra and Chan, 2014). Notably, in 
stem-like cells, aged mitochondria are differentially inherited during asymmetric 
divisions that ensure acquisition of healthy mitochondria by more stem-like daughters 
(Katajisto et al., 2015). Here, we sought to dissect the coupling of discordant 
lymphocyte fate outcomes to cell biological signaling at the interface of PI3K, 




















Unequal Clearance of Aged Mitochondria Modulates B and T Cell Fate 
 
We first explored the role of mitochondrial quality control in lymphocyte cell fate 
bifurcations using in vitro models of terminal differentiation. B cells stimulated with LPS 
undergo terminal differentiation, as evidenced by repression of the lineage determining 
transcription factor Pax5 and upregulation of IRF4 (Lin et al., 2015). Similarly, CD8+ T 
cells undergo differentiation coupled to irreversible silencing of the transcription factor 
TCF1 following peptide-based TCR stimulation (Lin et al., 2016). As these differentiation 
programs are linked to PI3K signaling, we assessed the role of mitochondrial clearance 
through genetic and pharmacological approaches to interfere with Dynamin-related 
protein 1 (Drp1), a protein essential for mitochondrial fission and autophagy (Mishra and 
Chan, 2014). Transduction of activated B and T cells with retrovirus encoding dominant-
negative (DN) Drp1, or pharmacological inhibition of Drp1 with mDivi-1, both led to 
enhanced plasmablast and effector T cell differentiation, respectively, as indexed by 
Pax5 and TCF1 repression (Figure 2.1A). In addition, DN Drp1 transduction and mDivi-
1 treatment induced a reciprocal increase in IRF4 expression in B cells (Figure 2.1A). 
These results suggest that mitochondrial turnover and/or clearance is required for 
regulating the balance of effector and memory cell differentiation. 
  
A)





Figure 2.1. Inhibition of mitochondrial turnover drives terminal 
lymphocyte differentiation. (A) Upper left: Pax5 and IRF4 expression by B 
cells labeled with CTV and activated with LPS and transduced with retrovirus 
(RV) encoding dominant-negative (DN) Drp1 at 36 hrs post-stimulation. Graphs 
denote the frequency of Pax5-lo (n = 4; ** p<0.01 Paired t test) and IRF4-hi (n = 
3; * p<0.05. Paired t test) cells among B cells transduced with control or DN 
Drp1 RV. Lower left: TCF1 expression by CTV-labeled CD8+ T cells stimulated 
with anti-CD3/CD28 antibodies and IL-2 for 36 hr, then transduced with control 
or DN Drp1. Graph indicates the frequency of TCF1-lo T cells among cells 
transduced with control or DN Drp1 RV (n = 3; * p<0.05 Paired t test). Upper 
right: CTV-labeled B cells from wild-type mice were stimulated with LPS in the 
absence or presence of mDivi-1. Graphs indicate the frequency of Pax5-lo and 
Pax5-lo/IRF4-hi B cells (n = 7; *** p<0.001. Paired t test). Lower right: CTV-
labeled P14 transgenic CD8+ T cells were stimulated with gp33-41 and IL-2 for 
4 days in the absence or presence of mDivi-1. Graph indicates the frequency of 
TCF1-lo T cells among cells activated in the absence or presence of mDivi-1 (n 
= 5; **p<0.01. Paired t test). (B) Mitoclearence assay. MitoTracker Green FM 
(MTG)-pulsed labeled B cells (top row) and P14 CD8+ T cells (bottom row) were 
activated as in (A). Cells were cultured in the absence or presence of mDivi-1, 
Chloroquine, or rapamycin as indicated. Y-axis reflects dilution plus elimination 
of pre-labeled (pulsed) mitochondria, termed mitoclearance, in relation to cell 
division (x axis). Graph statistics denote frequency of cells within trapezoidal 
MTG-low gate (n = 3; *p<0.05 ** p<0.01 ***p < 0.001 for indicated treated 
groups compared to no drug control group, repeated-measures one-way 
ANOVA). (C) CTV-labeled B cells (upper row) and P14 CD8+ T cells (lower row) 
stimulated with LPS or gp33-41 peptide and IL-2, in the absence or presence of 
mDivi-1 and analyzed for mitochondrial ROS (mROS) production by MitoSOX
staining. Horizontal numbers denote the frequency of cells within gate. Vertical 
numbers denote MFI of all cells. Graphs display MitoSOX MFI among cells 
stimulated with or without mDivi-1 (n = 3; * p< 0.05. Paired t test).
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Mitochondrial turnover, mediated by fission and fusion, facilitates the degradation 
of aged and dysfunctional mitochondria through a specific form of macro-autophagy 
termed ‘mitophagy’ (Eiyama and Okamoto, 2015). We sought to determine whether 
inhibition of Drp1 activity promotes terminal lymphocyte differentiation by altering 
mitochondrial clearance. A fluorescence-based, pulse chase method was developed to 
quantify clearance of aged mitochondria in relation to cell division through flow 
cytometry (Figure 2.1B). Prior to activation, lymphocytes were pulsed with a fluorescent 
mitochondrial dye to label the total mitochondrial content of the naïve B or T cells. 
Following activation, dilution of the mitochondrial dye, as quantified by flow cytometry, 
provided a readout of both passive apportioning and active degradation of the original 
mitochondrial population (Figure 2.1B). Treatment with mDivi-1 increased stasis of aged 
(pulse-labeled) mitochondria, as seen by greater maintenance of pulsed fluorescent 
dye. This stasis was comparable to that observed following treatment with the general 
macro-autophagy inhibitor chloroquine and opposite that following treatment with an 
inducer of autophagy (rapamycin) (Figure 2.1B). Notably, inhibition of mitochondrial 
fission following treatment with mDivi-1 also increased production of mROS by both B 
and CD8+ T cells (Figure 2.1C). Taken together, these results suggest that lymphocytes 
actively turn over their mitochondria pool following activation and that stasis of aged 
mitochondria is associated with terminal lymphocyte differentiation. 
 
Unequal clearance of aged mitochondria during T and B cell differentiation in vivo 
To determine whether mitochondrial clearance was associated with lymphocyte 
cell fate during the response to infection in vivo, we assessed CD8+ and CD4+ T cell 
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differentiation following infection. Because inheritance of aged mitochondria was evident 
for at least six cell generations (Figure 2.1B), we reasoned that unequal inheritance 
could be associated with cell fate bifurcations in vivo. At 3 days following infection with 
L. monocytogenes expressing gp33, terminally differentiated CD8+ KLRG1+ T cells, 
which are phenotypically TCF1-low (Lin et al., 2016), were enriched with aged 
mitochondria (Figure 2.2). At 4 days following respiratory infection with influenza virus, 
CD4+ Th1 effector cells (largely TCF1-low) left the draining lymph node to populate the 
lung, while self-renewing TCF1-hi central memory cells recirculated through non-
draining nodes (Nish et al., 2017b). Effector cells in the lung were enriched for the stasis 
of aged mitochondria (Figure 2.2). Self-renewing CD4+ T cells localized to the non-
draining lymph node were reciprocally enriched for heightened clearance of aged 
mitochondria (Figure 2.2). Taken together, these results indicate that lymphocyte 
progeny destined for terminal differentiation in vivo are marked by the stasis of aged 
mitochondria.  
  
Figure 2.2 Mitochondrial stasis marks lymphocyte progeny destined for 
terminal differentiation in vivo. CTV and MTG pulse-labeled P14 CD8+ T 
cells (top row) and OT-II CD4+ T cells (bottom panels) were adoptively 
transferred into congenically disparate recipients challenged with Listeria 
(LMgp33) or PR8-OVA influenza virus, respectively. For CD8+ T cells, the left 
plot depicts cell division versus mitoclearance for non-transferred cells as a 
control for initial MTG fluorescence. Middle and right plots show mitoclearance 
by P14 CD8+ donor T cells for KLRG1- (TCF1-hi) and KLRG1+ (TCF1-lo) 
populations at 3 days post Listeria challenge. Results are representative of two 
independent experiments. For CD4+ T cells, the upper row depicts cell division 
versus mitoclearance in draining lymph nodes (LNs), non-draining LNs, and 
lung tissue; the bottom row depicts cell division versus TCF1 expression. 
Numbers are the frequency within gates encompassing divided cells. Results 
are representative of two independent experiments. 
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Asymmetric elimination of aged mitochondria during late cytokinesis 
Unequal inheritance of aged mitochondria by different subsets at the population level 
could reflect signaling and turnover of organelles in interphase cells. However, given the 
uniform nature of the stimuli used in our modeled differentiation systems, we reasoned 
that it was unlikely for individual interphase cells to undergo asynchronous, divergent 
metabolic signaling. We therefore assessed the localization of aged mitochondria in 
mitotic cells using confocal microscopy, speculating that asymmetric division could 
facilitate the observed differences. However, we found that the subcellular distribution of 
aged mitochondria was generally symmetric in metaphase and early telophase cells 
(Figure 2.3A). In cytokinetic daughter cell pairs, however, the inheritance of aged 
mitochondria was frequently discordant (Figure 2.3A). Furthermore, in live cell imaging 
assays, we observed cytokinetic daughter cell pairs with stable discordant levels of 
aged mitochondria over extended periods of time (Figure 2.3B). This localization and 
inheritance pattern suggested that differential apportioning of aged mitochondria is not 
the principal mechanism for establishing asymmetry in lymphocytes, despite prior 
reports in stem-like cells (Katajisto et al., 2015), but rather that inequality was 
associated with clearance/degradation during cytokinesis. 
  
Figure 2.3 Asymmetric elimination of aged mitochondria during late 
cytokinesis. (A). MitoTracker Red FM (MTR)-pulsed, LPS-stimulated B cells fixed 
after 44 hr and stained with DNA dye and anti-tubulin antibodies. One representative 
metaphase (symmetric), telophase (symmetric), and cytokinetic (asymmetric) event 
is shown. Results are representative of 3 independent experiments. (Pooled number 
of events: metaphase, n = 11 cells; telophase, n = 8 sibling pairs; cytokinesis, n = 18 
sibling pairs). The graph depicts the percentage of sibling cell pairs with equal or 
unequal ratios of MTR and tubulin (*p < 0.05, Fisher’s exact test). (B) Live cell 
imaging of LPS-stimulated B cells transduced with mCherry-alpha-tubulin RV and 
pulsed labeled with MTG 16 hr prior to imaging. 2 representative time lapse series 
are shown. Frames, left to right, represent 3-min (upper row) and 2-min (lower row) 





Notably, the clearance of aged (pulse-labeled) mitochondria was also coordinate 
with the clearance of aged (pulse-labeled) lysosomes (Figure 2.4A), suggesting that 
stasis of membrane bound organelles is implicated in homeostatic pathways associated 
with degradation. To determine whether unequal mitochondrial clearance correlated 
with cell fate, we sorted self-renewing Pax5(hCD2)-hi and terminally differentiated 
Pax5(hCD2)-lo cells from the same range of late cell divisions, and stained 
mitochondria alongside lysosomes or autophagosomes to obtain a quantitative measure 
of mitophagy. Lysosomes were labeled with the fluorescent dye Lysotracker Deep Red, 
while CytoID, a fluorescent probe (Enzo Life Sciences) that specifically labels 
autophagosomes, was used to visualize autophagy (Chan et al., 2012; Guo et al., 
2015). Steady state co-localization of mitochondria with lysosomal or autophagic puncta 
was infrequent. However, co-localization was more frequently observed in self-renewing 
cells that had maintained Pax5 expression (Figure 2.4B). Additionally, mDivi-1 
treatment, which reduced mitoclearance by flow cytometry (Figure 2.1A), decreased the 
steady-state incidence of co-localization between mitochondrial and lysosomes in 
Pax5hi cells (Figure 2.4B). Taken together, these results suggest that the stasis of aged 
mitochondria is a feature of terminal differentiation in T and B cells. 
A)
B)
Figure 2.4. Unequal mitochondrial clearance is associated with 
differential mitophagy. 
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Figure 2.4. Unequal mitochondrial clearance is associated with differential 
mitophagy. (A). Live cell imaging of LPS-stimulated B cells transduced with mCherry-
alpha-tubulin RV and co-pulsed with Mitotracker Green (MTG) and LysoTracker 16 hr
prior to imaging. Images show 2 representative cytokinetic daughter cell pairs. Of the 
cells imaged, 73% had concordant asymmetric MTG and LysoTracker abundance (n = 
11 sibling pairs). (B) Live cell imaging of mitophagy in activated B cells. Pax5-hCD2 
reporter B cells were stimualted for 3 days with LPS and sorted based on surface hCD2 
expression. Cells were then labeled with MTG and LysoTracker DeepRed (top panels) 
or CytoID and MTR. Steady-state mitophagy was determined by co-localization of 
mitochondrial puncta with LysoTracker or CytoID puncta. Top left graph indicates the 
number of co-localized MTG/LysoTracker DeepRed puncta for Pax5-hi (n = 35) and 
Pax5-lo (n = 17) cells. *** p<0.001, Mann-Whitney test. Top right graph indicates the 
number of co-localized MTG/LysoTracker DeepRed puncta, amongst Pax5-hi cells 
sorted from cultures stimulated in the absence (n = 15) or presence (n = 21) of mDivi-1. 
***p<0.005, Mann-Whitney test. Bottom graph indicates the number of co-localized 
MTR/CytoID puncta amongst Pax5-hi (n = 14) and Pax5-lo (n = 19) cells (*p < 0.05, 
Mann-Whitney test). Scale bars, 5 uM. Fourth panel in each row is a zoomed-in version 
of the third panel. 
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Asymmetric localization and inheritance of autophagosomes mediated by PI3K 
Our results suggest that differential degradation could contribute to the observed 
inequalities in inheritance of aged mitochondria. Mitophagy converges with the 
macroautophagy pathway to direct degradation of bulk substrates (Green et al., 2011). 
To determine whether asymmetric autophagy mediates unequal mitochondrial 
elimination, we visualized autophagosomes with fluorescence dyes in mitotic B cells. 
Crucially, we found that the organelles were strikingly asymmetric in conjoined sibling 
cells (Figure 2.5). Given that aged mitochondria were generally symmetric in metaphase 
cells, it remained unclear at what stage in the cell cycle the signaling network that 
orchestrates this asymmetric autophagy becomes active. We found that asymmetry of 
autophagosomes was consistent as early as prometaphase (Figure 2.5). These results 
suggest that asymmetry of signals promoting the formation and/or localization of these 
degradative organelles occurs early in mitosis. 
Formation of the isolation membrane of nascent autophagosomes is directed by 
Vps34 and inhibited by Class I PI3K/Akt/mTOR signaling. We therefore determined 
whether inhibition of PI3K activity could perturb autophagosome asymmetry in 
metaphase and cytokinetic as a candidate signaling machinery for orchestrating 
polarize inheritance of subcellular organelles related to metabolism. We found that 
treatment of B cells with LY294002 resulted in a consistent decrease in CytoID 
fluorescence, consistent with a role for Class III PI3K activity in initiating 
autophagosome formation. Nevertheless, autophagosome puncta were clearly 
visualized in both no drug and LY294002-treated cultures and exhibited the same 
morphology (Figure 2.5). Critically, inhibition of PI3K activity resulted in a more 
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symmetric distribution of autophagosomes in both metaphase and cytokinetic cells 
(Figure 2.5). Taken together, these results suggest that asymmetry of the autophagy 
machinery correlates with unequal degradation of aged mitochondria in dividing 


















No drug PI3K inhibitor
Figure 2.5 PI3K drives asymmetric autophagy in mitotic lymphocytes 
Live cell imaging of autophagosome localization in LPS-stimulated B cells 
transduced with mCherry-tubulin and labeled with CytoID. Cells were 
stimulated with or without LY2920042. Upper: Representative images of 
metaphase and cytokinetic cells, with or without inhibitor. Lower:  
Proportion of asymmetric metaphase cells for No drug (83%) and PI3K 
inhibitor treatment (25%); proportion of asymmetric cytokinetic cells for No 
drug (77%) and PI3K inhibitor treatment (30%). ** p<0.01. Fisher’s Exact 



















Mitochondrial quality control and dynamics are key pathways that impinge on cellular 
and organismal homeostasis. The regulation of these mitochondrial pathways has been 
associated with normal growth and development, stem cell self-renewal, tissue 
remodeling, cellular metabolism, and healthy aging (Mishra and Chan, 2014). Clearance 
of aged mitochondria promotes self-renewal of hematopoietic, muscle, and breast stem 
cells as well as natural killer cells (García-Prat et al., 2016; Ito et al., 2016; Katajisto et 
al., 2015; O'Sullivan et al., 2015).  Similarly, mitochondrial biogenesis (Bengsch et al., 
2016; Scharping et al., 2016) and fusion (Buck et al., 2016; Khacho et al., 2016; 
Luchsinger et al., 2016) also support self-renewal of hematopoietic, neural, and memory 
T cells.  Mitochondrial dynamics might therefore facilitate cellular self-renewal by 
eliminating dysfunctional organelles, while concurrently generating new organelles and 
fusing mitochondria to optimize the efficiency of oxidative metabolism as well as overall 
mitochondrial fitness. In this study, we show that unequal elimination of aged 
mitochondria is associated with cell fate bifurcations in lymphocytes and further that 
perturbation of this homeostatic pathway can alter lymphocyte differentiation. 
Asymmetric inheritance of autophagosomes, as driven by PI3K signaling earlier in 
mitosis, is associated with and may drive unequal clearance of mitochondria.  
 These findings support a model wherein mitochondrial stasis is part of a larger 
constellation of cellular metabolic signaling and autophagy. which may be associated 
with differentiation ROS production and inactivation of the key transcription factor 
FoxO1. Conversely, mitochondrial clearance appears to be part of a larger catabolic 
constellation of AMPK activation, autophagy, mitochondrial elimination, oxidative 
metabolism, maintenance of FoxO1 activity, and Pax5 or TCF1 expression. The 
 43 
metabolic pathways implicated in unequal autophagy and mitochondrial elimination may 




MATERIALS AND METHODS 
Mice  
All animal work was conducted in accordance with Institutional Animal Care and Use 
Guidelines of Columbia University. Mice were housed in specific-pathogen-free 
conditions. Both male and female mice were used, and all mice were between 6-8 
weeks of age. Strains used include: C57BL/6 (wild type), P14 TCR transgenic (P14) 
recognizing LCMV peptide gp33-41/Db, OT-II, and Pax5-IRES-hCD2 reporter mice 
(Fuxa and Busslinger, 2007).  
 
In vitro lymphocyte activation  
Spleens from mice of the indicated genotypes were isolated and processed using 
established protocols. Wild type B cells were enriched from splenocytes using magnetic 
bead negative selection kits (Miltenyi Biotec). B cells were stimulated with 20ug/mL LPS 
and polyclonal CD8+ T cells were stimulated with plate-bound anti-CD3/CD28 (1ug/mL) 
supplemented with 100IU/mL IL2. For experiments with P14 CD8+ T cells, bulk 
splenocytes were activated with gp33 peptide (1ug/mL) as previously described (Lin et 
al., 2016). In all experiments, lymphocytes were labeled with Cell Trace Violet (CTV) 
prior to stimulation according to the manufacturer’s instructions to monitor cell division 
number. Where indicated, cells were treated with LY294002 (pan PI3K-inhibitor, Cell 
Signaling Technology, used at 2.5-5uM). 
 
Retroviral Transduction  
Enriched B cells or CD8+ T cells were stimulated with LPS or plate-bound anti- 
CD3/anti-CD28 antibodies plus IL-2, respectively, for 36 hr prior to retroviral 
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transduction. Cells were then re-plated in supernatant collected prior to transduction. 
Retroviral constructs used were as follows: mCherry-a-tubulin fusion; mouse dominant-
negative Drp1(K38A), a gift from David Chan (Addgene plasmid 26049) and 
subsequently cloned into the MSCV-IRES-Thy1.1 plasmid, a gift from Anjana Rao 
(Addgene plasmid 17442). Empty MSCV-IRES-Thy1.1 or MSCV-IRES-GFP vectors 
were used as controls.  
 
In vivo infection  
For in vivo experiments of CD8+ T cell differentiation, 1-3x10^6 TCF7-GFP reporter P14 
CD8+ T cells were adoptively transferred intravenously (i.v.) into allotype-disparate 
C57Bl/6 wild-type mice, which were subsequently infected with 5x10^3 CFUs of L. 
monocytogenes expressing gp33 (LM-gp33) via i.v. injection. Spleens were harvested 
at day 4-5 of infection, and CD8+ T cells were then MACS enriched for cell sorting of 
transferred, TCF7-GFP+ P14 cells. For experiments on tissue homing of Th1 CD4+ T 
cells, 1-3x10^6 OT-II Thy1.1+ CD4 T cells were purified, pulse-labeled with CTV and 
MitoTracker Green FM, and then adoptively transferred into Thy1.2+ recipients 24 hr 




Single-cell suspensions were prepared and stained as previously described (Lin et al., 
2015). For staining of transcription factors, the eBioscience Foxp3 kit was used. 
Antibodies used in this study include: IRF4 (3E4 eBioscience), TCF1 (C63D9, Cell 
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Signaling Technology), and Pax5 (1H9, eBioscience). BD LSRII and Fortessa flow 
cytometers were used to analyze cells. Data were analyzed using FlowJo (Tree Star). 
 
Organelle Pulse Labeling  
Cells were labeled with Cell Trace Violet (CTV; Thermo Fisher Scientific) prior to 
stimulation to track cell division. Mitochondria were pulse-labeled with MitoTracker 
Green FM or MitoTracker Red FM (200 nM) at 37 C for 15 min. Lysosomes were 
labeled with LysoTracker Deep Red (Thermo Fisher Scientific; 50–75 nM) for 30 min at 
37 C in media. Autophagosomes were labeled with CytoID (Enzo Life Sciences). 
Labeling steps were followed by at least two washing steps in cell culture media. 
 
Confocal Microscopy 
Immunofluorescence microscopy of mitotic B and T cells was performed as previously 
described (Lin et al., 2015). Briefly, cells were adhered to poly-l-lysine (Sigma) coated 
coverslips and fixed with freshly prepared 3.7% paraformaldehyde followed by 
permeablization with 0.3% Triton X-100. Cells were then blocked in buffer containing 
0.01% saponin and 0.25% fish skin gelatin (Sigma) in PBS+ and stained with antibodies 
to the indicated proteins. Antibodies used include: a-tubulin (YOL1/34, Abcam). All 
Alexa Fluor dye-conjugated secondary antibodies were obtained from Thermo Fischer. 
Imaging was performed on Nikon Ti-Eclipse inverted scanning confocal or spinning disk 
confocal microscopes. Images were processed with ImageJ software. Metaphase cells 
were identified by the presence of two microtubule organizing centers (MTOC) with 
opposed spindle poles. Late telophase/cytokinetic cells were identified by the presence 
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of a characteristic tubulin bridge and cytoplasmic cleft. For quantification of asymmetry 
in mitotic cells, fluorescent signal was thresholded to remove background, and the 
integrated fluorescence density in each nascent daughter cell or half of the metaphase 
plate was calculated. Statistical significance was assessed using GraphPad Prism and 
specific statistical tests are indicated in each figure legend. 
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Chapter 3: PI3K organizes a polarity and asymmetry pathway in lymphocytes 
 
Portions of this Chapter have been adapted from the following manuscripts: 
 
Chen YH*, Kratchmarov R*, Lin WH*, Rothman NJ, Yen B, Adams WC, Nish SA, 
Rathmell JC, and Reiner, SL. (2017). Asymmetric PI3K Activity in Lymphocytes 
Organized by a PI3K-mediated Polarity Pathway. Cell Reports. In revision. 
 




Cell intrinsic polarity pathways in lymphocytes have remained enigmatic, though 
previous work has implicated localized PI3K activity in the formation of the 
immunological synapse and cytotoxic T cell degranulation. Here, we show that 
activation of B and T cells induces internalization and polarized inheritance of antigen 
receptors. Additionally, activated lymphocytes had elevated PI3K signaling which 
subsequently induced the formation of PIP3 lipid-positive intracellular vesicular 
structures. Intracellular PIP3 exhibited polarized subcellular organization at the MTOC, 
co-localizing with antigen receptors. In mitosis, PIP3 and CD3 exhibited concordant 
asymmetry, with intracellular structures partitioning to the same side of metaphase cells. 
These results provide evidence for asymmetric, spatially constrained Class I PI3K 
activity in vitro and in vivo. Furthermore, we observed polarized regional trafficking and 
inheritance of the facultative glucose transporter Glut1, the expression of which was 
found to mark cells destined for terminal differentiation. Critically, perturbation of Class I 
PI3Kd activity abrogated terminal effector differentiation and induced a striking loss of 
receptor and transporter polarity. Taken together, these results suggest that the distinct 
roles of PI3K signaling in cell growth, regulation of gene expression, and polarity may 
direct unequal cell fate outcomes. 
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Introduction 
After synapsing with an antigen presenting cell (APC), a selected T cell clone divides to 
yield a more activated, proliferative, and differentiation-prone daughter cell alongside a 
less activated and more quiescent sibling cell (Arsenio et al., 2014; Chang et al., 2007; 
Pollizzi et al., 2016; Verbist et al., 2016). After 3 or 4 more divisions, progenitor cells 
differentiate and bifurcate in fate to irreversibly determined effector cells with de novo 
silencing of TCF1 expression, alongside self-renewing memory precursor cells that 
maintain TCF1 expression and the bipotency to yield daughter cells with discordant 
silencing of TCF1 (Adams et al., 2016; Lin et al., 2015; Lin et al., 2016; Nish et al., 
2017b). 
It remains unclear how lymphocyte progenitors undergoing these later divisions 
can organize signals in the absence of a defined external polarity cue. In vivo, the first T 
cell division as well as pre- and intra-germinal center B cell divisions leading to plasma 
cell selection occur in the context of an extrinsic contact, namely an APC interfacing 
with a T cell, and antigen or T cell help directing a B cell. Thus, polarity and asymmetry 
of immune synapse components such as the antigen receptor, integrins, and cytokine 
receptors preceding a cell division may confer an asymmetry cue to daughter cells. 
When activated lymphocyte progenitors divide asymmetrically after 4 or more divisions 
in vivo, however, it is not obvious what the polarizing stimulus might be. Furthermore, 
modeled differentiation conditions in vitro, i.e. B cells stimulated with LPS in buoyant 
media, or T cells stimulated with peptide/immobilized antibodies, induce asymmetric 
division without a clear extrinsic cue. 
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To further elucidate the nature of asymmetric fate outcomes in late division 
lymphocytes, we considered cell-intrinsic mechanisms that do not depend on the 
polarity network or an extrinsic cue. Endosomal vesicular traffic can direct asymmetric 
division independent of PAR proteins and engages in crosstalk with Class II PI3K 
activity (Emery et al., 2005). Furthermore in lymphocytes, endocytosis of antigen 
receptors sustains activating signals and therefore plays an essential role in anabolic 
induction and sustained proliferation, in vitro and in vivo (Chaturvedi et al., 2011; 
Willinger et al., 2014). Endocytosis and anabolic signals via internalized antigen 
receptor do not require the continuing presence of an antigen presenting cell and can 
direct extensive proliferation, differentiation, and memory formation in subsequent 
generations of cells that had not contacted antigen directly (Kaech and Ahmed, 2001). 
Furthermore, anabolic signaling in the form of PI3K activity may have evolved to 
facilitate spatial segregation. Cell migration, axon growth, apico-basal polarity, and 
asymmetric skin progenitor cell division are all mediated by localized PI3K activation. 
We therefore assessed whether endocytosis and unequal anabolic signaling to cellular 










Compartmentalized PI3K activity associated with CD8+ T cell terminal 
differentiation 
PI3K signaling drives effector CD8+ T cell differentiation and is required for asymmetric 
divisions that generate sibling cells with TCF1-high and low expression respectively (Lin 
et al., 2015). In our previous studies, we found that CD8+ T cells repress TCF1 only 
after several divisions. We therefore became interested in how these later cell 
generations could maintain polarized anabolic activity in the absence of an obvious 
external polarity cue. In lymphocytes, the microtubule organizing center (MTOC) is a 
candidate polarity landmark to orient unequal compartmentalization of signaling in 
relation to the axis of cell division. PI3K activity directs cellular traffic such as peri-
centrosomal recycling, ciliogenesis, actin dynamics at the immune synapse, and Glut1 
trafficking (Marat and Haucke, 2016). To assess the relationship between vesicular 
traffic and the MTOC, we activated P14 CD8+ T cells in vitro with gp33 peptide, and 
imaged cells through confocal IF microscopy at day 3-4 post-activation when cells had 
undergone several divisions and began to repress TCF1 (Figure 3.1A). As endocytosis 
is critical for sustained TCR signaling and anabolic activity (Willinger et al., 2014), we 
first examined the subcellular localization of CD3. Unstimulated T cells had diffuse CD3 
expression throughout the plasma membrane. Upon TCR stimulation, CD3 became 
polarized and localized intracellularly to the MTOC (Figure 3.1A). This polarity was 
maintained in dividing cells, as CD3 was found to be asymmetric at metaphase during 
these later divisions. We then examined the subcellular distribution of PIP3, a lipid 
signaling intermediate generated by active PI3K. We found that PIP3+ membranes were 
primarily found in discrete puncta that frequently localized to the MTOC of later-division 
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T cells, in both interphase and metaphase (Figure 3.1B). This localization was 
concordant with intracellular CD3 polarity. Critically, metaphase cells with asymmetric 
PIP3 also exhibited concordant CD3 asymmetry (Figure 3.1B). Examination of CD98, a 
receptor implicated in asymmetric mTOR induction in first-division T cells (Pollizzi et al., 
2016; Verbist et al., 2016), revealed that asymmetric localization of CD3 was not 
accompanied by coordinate asymmetry of CD98 (Figure 3.2) suggesting that 
receptor/PIP3 asymmetry involves regulated localization rather than non-specific 




















































































Figure 3.1. Asymmetric division of functional PI3K activity in CD8+ T cells
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Figure 3.1. Asymmetric division of functional PI3K activity in CD8+ T cells
(A) Confocal immunofluorescence (IF) microscopy analysis of CD3 localization 
in unstimulated (N=16) or gp33 peptide-stimulated interphase P14 CD8+ T 
cells activated for 3 days (N=23).
(B) Top, CD3 and PIP3 localization in interphase and metaphase P14 blasts at 
day 3 post-activation. Bottom left, quantification of CD3 and PIP3 asymmetry in 
metaphase cells. **** p<0.001. Chi Square test with Bonferroni’s Correction. 
Bottom right, amongst PIP3 asymmetric cells, proportion with CD3 asymmetric 
concordant (same MTOC), CD3 asymmetric discordant (opposite MTOC), or 
CD3 symmetric localization. 
(C) Left, Glut1 localization in interphase and metaphase P14 blasts. Right, 
quantification of Glut1 asymmetry in metaphase cells.  **** p<0.001. Fisher’s 
Exact test.
(D) CD8+ T cells expressing myc-tagged Glut1 were stimulated with anti-
CD3/CD28 + IL-2 for 3.5 days. Left, Surface Glut1 versus cell division, gated 
for high and low populations. Middle, TCF1 expression versus cell division 
within surface Glut1-high and low populations; Right, quantification of TCF1-low 
population frequency. * p<0.05. Paired T test. 
For all panels, dashed blue line denotes asymmetry cutoff value of 0.2, and 














































Figure 3.2 Specific receptor polarity and asymmetry is not 
accompanied by universal receptor polarity 
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Figure 3.2 Specific receptor polarity and asymmetry is not 
accompanied by universal receptor polarity Localization of 
CD98 and CD3 in interphase and metaphase P14 CD8+ T cells 
activated for 3 days as in Figure 3.1. Both 3-dimensional 
projection of the entire cell and a single z-slice in the plane of the 
MTOC or the mitotic spindle are shown. Quantification of CD3 
asymmetry relative to DNA in metaphase cells (**p<0.01) and 
CD98 symmetry (n.s. not significantly different than DNA). Chi 
Square Test with Bonferroni’s Correction.
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The previously reported observation that activated CD8+ T cells can continue to 
proliferate and differentiate after transfer to a naïve host led us to examine whether 
cellular asymmetry was dependent on contact with an antigen presenting cell (Kaech 
and Ahmed, 2001). We stimulated P14 CD8+ T cells in vitro and then sorted cells at 24 
hours post-activation (before the first cell division) to obtain a pure population of blasting 
lymphocytes and remove all APCs/antigen (Figure 3.3). Cells were then re-plated in 
fresh media containing IL-2 but no peptide and cultured for 3 days followed by IF 
microscopy analysis. Both CD3 and PIP3 were polarized in interphase cells and 
asymmetric in mitotic cells, albeit at a lower frequency than during in culture with APCs 
(Figure 3.3). These data suggest that CD8+ T cells can divide asymmetrically to 
generate sibling cells with unequal inheritance of endocytosed TCR, independent of 
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Figure 3.3. Sustained PI3K and antigen receptor polarity in the 
absence of peptide antigen
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Figure 3.3 Sustained PI3K and antigen receptor polarity in the 
absence of peptide antigen
P14 CD8+ T cells were stimulated with gp33 peptide as in Figure 
3.1 for 22 hours. Cells were then sorted before the first cell division 
to remove antigen and non-P14 splenocytes. Sorted cells were 
then re-plated in fresh media containing IL-2 without gp33 peptide. 
A.) Representative FACS plots of TCF1 expression versus cell 
division for: Left: unsorted P14 cells at day 3, Middle: sorted P14 
cells at 22 hours, Right: P14 cells 48 hours post-sort. Left two 
quadrants indicate divided TCF1 high and low populations. B.) 
Representative images of PIP3 and CD3 subcellular localization in 
interphase and metaphase cells 48 hours after sorting and antigen 
removal. C.) Left: Quantification of PIP3 and CD3 asymmetry in 
metaphase cells. **p<0.01. *p<0.025. Chi Square Test with 
Bonferonni’s Correction. Right: Proportion of PIP3 asymmetric cells 




Effector CD8+ T cell differentiation requires sufficient anabolic activation, with 
concomitant metabolic reprogramming toward aerobic glycolysis (Warburg effect). Glut1 
is the principal inducible glucose transporter in T cells and is upregulated upon TCR 
stimulation. Furthermore, PI3K signaling is essential for trafficking of Glut1 from 
recycling endosomes to the plasma membrane (Wofford et al., 2008). We examined the 
subcellular localization of Glut1 in late division CD8+ T cells. Glut1 was primarily found 
in discrete intracellular puncta, largely polarized to the MTOC, with some transporter 
also detectable in the plasma membrane (Figure 3.1D). In metaphase cells, Glut1 
continued to exhibit an intracellular localization pattern and was frequently asymmetric. 
To determine whether Glut1 expression is associated with terminal CD8+ T cell 
differentiation, we used surface Glut1 reporter mice expressing a myc-tag on the 
extracellular domain of Glut1 (Michalek et al., 2011). Myc-Glut1 CD8+ T cells were 
activated with TCR stimulation in vitro, and the relationship between surface Glut1 and 
TCF1 expression was analyzed by flow cytometry (Figure 3.1D). Consistent with the 
previously described role of Glut1 in anabolic activation of CD4+ T cells (Macintyre et 
al., 2014), cells expressing high levels of surface Glut1 were enriched for TCF1-low 
effector cells. Asymmetric inheritance of glucose transporters may therefore be 
associated with TCF1 repression and terminal differentiation of CD8+ T cells. Taken 
together, these findings suggest that a spatially restricted network of PI3K signals 
organize polarity and asymmetry of key signaling factors including nutrient receptors 




Asymmetric PI3K activity drives unequal BCR and glucose transporter 
inheritance in B cells  
Given the polarity and asymmetric inheritance of CD3 observed in CD8+ T cells, we 
sought to determine whether activated B cells also exhibit compartmentalized anabolic 
signaling. LPS-stimulated B cells transmit PI3K and other critical activating signals 
through CD19 and IgM (Keppler et al., 2015; Schweighoffer et al., 2017). We therefore 
first determined whether IgM exhibits asymmetric inheritance during B cell divisions 
associated with cell fate bifurcations in vitro. Terminally differentiated plasmablasts are 
generated in response to both T-cell dependent and independent antigens. In vitro-
modeled differentiation of B cells utilizing LPS-stimulation recapitulates the subset 
dynamics observed during in vivo immunization and is characterized by a bifurcation of 
self-renewing Pax5-hi B cells and differentiated Pax5-lo plasma cells (Lin et al., 2015; 
Xu et al., 2015a). To determine whether soluble LPS signals can trigger 
compartmentalized anabolic activity, we performed IF microscopy analysis of IgM in B 
cells at day 3 post-activation. Compared to unstimulated B cells, B cells receiving tonic 
TLR stimulation for 3 days had predominantly intracellular IgM, which was polarized to 
the MTOC (Figure 3.4A). These results are in accordance with previous working 
documenting rapid internalization of BCR following acute BCR stimulation (Chaturvedi 
et al., 2011). The polarity of IgM was maintained in dividing B cells, as IgM exhibited an 
asymmetric distribution from prophase through cytokinesis (Figure 3.4A). Asymmetry of 
IgM may reflect global unequality in antigen signaling in light of the previously observed 







































































































































Figure 3.4. Asymmetric division of functional PI3K activity in B cells
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Figure 3.4. Asymmetric division of functional PI3K activity in B cells
(A) Confocal IF microscopy analysis of IgM localization in LPS-stimulated 
B cells at day 3 post-activation. Left, IgM localization in unstimulated 
(resting) interphase (N=16) or LPS-stimulated interphase and mitotic B 
cells (N=19). Right, quantification of IgM asymmetry in metaphase and 
cytokinetic cells. **** p<0.0001. *** p<0.001. Fisher’s Exact test.
(B) Upper, Glut1 localization in LPS-stimulated mitotic B cells at indicated 
stages of cell cycle. Lower, quantification of Glut1 asymmetry in 
metaphase cells. **** p<0.0001. Fisher’s Exact test.
(C) B cells expressing myc-tagged Glut1 stimulated with LPS for 3.5 days. 
Left, surface Glut1 versus cell division, gated for high and low populations. 
Middle, Pax5 expression versus cell division within the surface Glut1-high 
and low populations. Right, quantification of Pax5-low population 
frequency. *p<0.05. Paired T test. 
(D) Class-switched (IgM-negative), resting memory B cells stimulated with 
LPS and analyzed by IF microscopy on day 3 post-activation. Left, 
subcellular localization of PIP3 and Glut1 in interphase and metaphase 
blasts. Middle, quantification of PIP3 and Glut1 asymmetry in metaphase 
cells. **** p<0.0001. *** p<0.001. Chi Square test with Bonferroni’s 
Correction. Right, amongst cells with asymmetric PIP3, proportion of 




BCR stimulation induces metabolic reprogramming of B cells with increased 
glycolytic flux and expression of the facultative glucose transporter Glut1, which is 
required for efficient differentiation of antibody-secreting plasma cells in vivo (Caro-
Maldonado et al., 2014). We therefore assessed whether differences in active glucose 
transport are associated with B cell fate bifurcations marked by Pax5 repression in vitro. 
When we examined the subcellular localization of Glut1, we found that LPS-stimulated 
interphase B cells had polarized Glut1, predominantly localized to intracellular vesicles 
(Figure 3.4B). Furthermore, intracellular Glut1 was asymmetric in mitotic B cells, 
indicating that a soluble stimulus can induce polarization of the anabolic machinery. We 
then sought to correlate Glut1 activity with B cell fate. B cells expressing myc-tagged 
Glut1 were stimulated with LPS and assessed by flow cytometry on day 3 post-
activation for Pax5 expression. As with CD8+ T cells, B cells that expressed high levels 
of surface Glut1 were enriched for the Pax5-low plasmablast subset (Figure 3.4C). Of 
note, surface Glut1-high B cells that had passed the third division abruptly became 
significantly enriched for the Pax5-low subset. 
We next asked whether polarized vesicle traffic in activated B cells is associated 
with spatially restricted PI3K signaling. It has previously been established that the 
induction of aerobic glycolysis following BCR stimulation relies on PI3K signals 
(Doughty et al., 2006). We therefore assessed the localization of PIP3+ vesicles in a 
modified in vitro model of differentiating B cells. Due to limitations in antibody clone 
availability, switched memory (IgM-) B cells were used. Sorted IgM- follicular B cells 
were stimulated with LPS as for previous experiments and then imaged at day 3 post-
activation. Notably, PIP3 was found to be polarized in interphase cells, as for CD8+ T 
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Cells (Figure 3.4D). Furthermore, polarity of PIP3 was concordant with Glut1, and PIP3 
vesicles were often asymmetric in metaphase cells. These findings are compatible with 
a model where BCR and TLR stimuli both converge on a scaffold of polarized CD19 and 




Inhibition of PI3K activity abolishes compartmentalized anabolic activity 
To determine the requirement of PI3K signaling for orchestrating polarity and 
asymmetry of antigen receptors and Glut1, we performed transient pharmacological 
inhibition experiments followed by IF imaging in B and T cells. P14 CD8+ T cells were 
activated in the presence or absence of LY294002, a pan-PI3K inhibitor. We then 
quantified interphase polarity and metaphase asymmetry of TCR. For interphase cells, a 
decentralization score was calculated based on the proximity of fluorescent puncta of 
molecule of interest relative to the MTOC (see Methods). While CD3 was polarized to 
the MTOC in the majority of the activated T cells, it was highly decentralized from the 
MTOC in cells that had abolished PI3K activity (Figure 3.5A). Inhibition of PI3K did not 
impair internalization of CD3, as it was still present in intracellular punctate structures. 
The decentralized pattern of CD3 in interphase cells lacking intact PI3K activity was 
phenocopied by treatment with Blebbistatin, an inhibitor of non-muscle myosin II (Figure 
3.5A). Myosin II is required for reorientation of the centrosome to the immune synapse 
upon antigen encounter by T cells (Le Floc'h et al., 2013). Loss of PI3K activity also 
disrupted CD3 asymmetry in metaphase cells for late-division CD8+ T cells (Figure 
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3.5B). Inhibition of non-muscle myosin II also disrupted PIP3 polarization to MTOC in 
interphase T cells (Figure 3.5C).  
In view of the importance of class I PI3K activity, particularly PI3Kδ, in antigen 
receptor signaling (Fruman et al., 2017; Lucas et al., 2016), we tested the effect of 
Idelalisib, a PI3Kδ-specific inhibitor, and Pictilisib, a pan-class I PI3K inhibitor on T cell 
fate, nutrient utilization, and polarity. Like LY294002, class I-specific PI3K inhibition 
resulted in defective silencing of TCF1, reduced cell surface trafficking of Glut1, 
diminished glucose uptake (Figure 3.5D), and defective CD3 polarity, though the latter 
defect was more severe in interphase than metaphase cells (Figure 3.5E). 
Inhibition of PI3K activity perturbed the asymmetry of endocytosed antigen 
receptors in both metaphase and cytokinetic B cells (Figure 3.5 F, G). As with CD8+ T 
cells, inhibition of PI3K activity also led to a disruption of polarity of Glut1 in interphase 
dividing B cells (Figure 3.5H). Taken together, our data suggest that PI3K activity 
organizes the polarity of endocytosed antigen receptors and may direct its own cellular 


















































































































































































































































































































































































Figure 3.5. PI3K-dependent polarity control of asymmetric PI3K signaling
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Figure 3.5. PI3K-dependent polarity control of asymmetric PI3K signaling
(A) P14 CD8+ T cells activated as in Figure 3.1 and treated with the indicated 
drugs to perturb polarity. Upper: CD3 localization in cells treated with No drug, 
LY294002, or Myosin II inhibitor (Blebbistatin). Lower right: CD3 
decentralization score in indicated treatment groups. *p<0.05. **p<0.01. n.s. 
not significant. Kruskal-Wallis non-parametric test. 
(B) Upper: CD3 localization in metaphase cells treated with No drug or PI3K 
inhibitor. Lower right: Quantification of CD3 asymmetry in indicated treatment 
groups. **p<0.01 Fisher’s Exact Test.
(C) Upper: PIP3 localization in interphase CD8+ T cells treated with No drug or 
Blebbistatin. Lower: PIP3 decentralization score in indicated treatment groups 
***p<0.001 Mann-Whitney U test.
(D) Class I PI3K-driven TCF1 repression and facultative glucose transporter 
function. Upper row, representative flow cytometry of cell division and TCF1 
expression at day 4 in the absence or presence of Idelalisib (PI3Kd inhibitor), 
Pictilisib (pan-class I PI3K inhibitor), or LY294002 (pan-PI3K inhibitor). 
Quantification of frequency of TCF1-repression. Lower left, representative flow 
cytometry and quantification of surface Glut1 detection in P14 CD8+ T cells 3 
days post-activation in the absence or presence of indicated inhibitors. Lower 
right, representative flow cytometry and quantification of fluorescent glucose 
analog 2-NBDG uptake in the absence or presence of the indicated inhibitors. 
*p<0.05 **p<0.01 **** p<0.0001 One way ANOVA. 
(E) Representative images of CD3 localization in interphase CD8+ T cells 
activated in the absence or presence of Idelalisib or Pictilisib. Decentralization 
score of indicated groups quantified. **p<0.01. ***p<0.001. Kruskal-Wallis non-
parametric test. Far right, quantification of CD3 asymmetry in metaphase 
CD8+ T activated in the absence or presence of Idelalisib p=0.05. Mann-
Whitney U test.
(F, G) Representative immunofluorescence images and quantification of IgM 
asymmetry in LPS-activated B cells in the absence or presence of LY294002
at metaphase (F) and cytokinesis (G). *p<0.05. Fisher’s Exact Test. 
(H) Representative images of Glut1 localization in interphase LPS-stimulated B 
cells in the absence or presence of LY294002. Decentralization score of 
indicated groups quantified. **p<0.01. Mann-Whitney U test.
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Asymmetric PI3K signaling and Glut1 inheritance in vivo  
To examine the compartmentalization and asymmetry of PI3K signaling in CD8+ T cells 
during an evolving infection in vivo, we employed the Listeria monocytogenes (L. 
monocytogenes) model. TCR transgenic P14 CD8+ T cells expressing a Tcf7GFP/+ 
reporter were transferred intravenously to naive recipient mice, followed by infection of 
the recipients with L. monocytogenes expressing the LCMV peptide gp33 (LMgp33). 
Spleens were harvested at day 4-5 post-infection, and Tcf7-GFPhi cells were sorted for 
analysis by confocal immunofluorescence microscopy. The majority of activated P14 
cells had undergone 4 or more rounds of division. As with T cells activated in vitro, we 
found that CD3 and PIP3 localized to intracellular puncta, which frequently associated 
with the MTOC and co-localized. CD3 and PIP3 puncta were also polarized to the 
MTOC during metaphase in these later-divisions in vivo (Figure 3.6A). Furthermore, the 
asymmetry of intracellular CD3 was concordant with PIP3 asymmetry. We found that 
Glut1 was also polarized in TCF1-hi interphase cells and asymmetric in metaphase cells 
in vivo (Figure 3.6B). Asymmetric Glut1 exhibited concordant sidedness with 
asymmetric PIP3 during metaphase (Figure 3.6C). Taken together, these results 
suggest that CD8+ T cells undergoing late divisions in vivo exhibit compartmentalized 
PI3K activity that correlates with asymmetric inheritance of antigen receptor and 

















































































































































 activity organizing unequal inheritance of antigen 
receptor and glucose transporter in vivo.
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Figure 3.6. Asymmetric PI3K activity organizing unequal inheritance of 
antigen receptor and glucose transporter in vivo.
(A) Polarization and asymmetric inheritance of CD3 and PIP3 in interphase 
and metaphase P14 CD8+ T cells in vivo during L. monocytogenes infection. 
FACS-sorted TCF7-GFP reporter P14 CD8+ T cells at day 4-5 post-infection 
analyzed by IF microscopy. Left: PIP3 and CD3 localization in interphase and 
metaphase blasts. Right, quantification of PIP3 and CD3 asymmetry in 
metaphase cells. **** p<0.0001. Chi Square Test with Bonferroni’s Correction.
(B) Polarization and asymmetric inheritance of Glut1 in vivo. Left: Glut1 
localization in interphase and metaphase P14 CD8+ T cells processed as in 
A. Right: Quantification of Glut1 asymmetry in metaphase cells. **** 
p<0.0001. Fisher’s Exact Test.
(C) Concordant polarity of PIP3 and Glut1 in vivo. Left: PIP3 and Glut1 
localization in metaphase P14 CD8+ T cells. Middle: Quantification of PIP3
and Glut1 asymmetry in metaphase cells. **** p<0.0001. Chi Square Test 
with Bonferroni’s Correction. Right: Proportion of PIP3 asymmetric cells with 
CD3 asymmetric concordant (same MTOC), CD3 asymmetric discordant 




While asymmetric division has been implicated in the diversification of lymphocyte cell 
fate following clonal selection, the mechanism underlying establishment and 
maintenance of asymmetry has been controversial. Notably, genetic studies assessing 
the role of the evolutionarily conserved PAR polarity network have yielded incomplete 
phenotypes (Nish et al., 2017a). This study provides evidence that class I PI3K 
phospholipid signaling triggered by antigen and costimulatory receptors, and measured 
by PIP3 production, is asymmetrically localized such that receptors and downstream 
protein targets, including Glut1, are unequally trafficked by its activity. Thus, class I 
PI3K signaling may couple glucose uptake, a requirement for terminal differentiation, 
with silencing of TCF1, the hallmark of effector T cells. Asymmetric localization of 
receptors that trigger PI3K activity is at least partly dependent on the Class I PI3K 
isoform δ. The convergence of PI3K-dependent metabolic, transcriptional, and cell 
polarity functions during cell division could orchestrate the balanced differentiation 
program necessary to generate effector and memory cells during differentiation of 
lymphocytes.  
Spatially segregated class I PI3K activity and accompanying cytoskeletal 
rearrangement is an evolutionarily conserved pathway for responding to environmental 
cues, including direction cell migration, axon outgrowth of neurons, immunological 
synapsis, apico-basal polarity, and asymmetric epithelial progenitor division (Dainichi et 
al., 2016; Engelman et al., 2006; Marat and Haucke, 2016). Endocytic trafficking 
mediated by class II and III PI3K signaling may potentially cooperate with Class I PI3K-
initiated polarity to maintain asymmetry through cell division; this model is consistent 
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with the finding that endocytosed antigen receptors can propagate anabolic activation 
(Willinger et al., 2014). Further, we found that inhibition of Class I PI3Kδ perturbed 
receptor polarity more completely in interphase than metaphase. Previous studies have 
documented that asymmetric division may be mediated by polarized endocytic 
trafficking independent of the PAR polarity network (Emery et al., 2005). Whether other 
PI3K isoforms and classes, mTOR activity, or PAR polarity proteins play complementary 
or downstream roles alongside class I PI3K, particularly in metaphase, will require 
further investigation. It also remains possible that a non-canonical extrinsic polarity cue, 
including T-T and B-B cell synapse, or else a cell-intrinsic lipid cue, may direct PI3K 
asymmetry in the context of late cell divisions following lymphocyte clonal activation. 
Nevertheless, these results suggest that PI3K may organize a cell-intrinsic polarity 

















All animal work was conducted in accordance with Institutional Animal Care and Use 
Guidelines of Columbia University. Mice were housed in specific-pathogen-free 
conditions. Both male and female mice were used, and all mice were between 6-8 
weeks of age. Strains used include: C57BL/6 (wild type), P14 TCR transgenic (P14) 
recognizing LCMV peptide gp33-41/Db, TCF7GFP/+ reporter P14 TCR transgenic (Zhou 
and Xue, 2012), and myc-Glut1 mice expressing Glut1 with a myc tag in the 
extracellular (surface) domain of the Glut1 transporter (Michalek et al., 2011).  
 
In vitro lymphocyte activation  
Spleens from mice of the indicated genotypes were isolated and processed using 
established protocols. Wild type B cells, myc-tagged Glut1 B cells, or myc-tagged Glut1 
CD8+ T cells were enriched from splenocytes using magnetic bead negative selection 
kits (Miltenyi Biotec). B cells were stimulated with 20ug/mL LPS and polyclonal CD8+ T 
cells were stimulated with plate-bound anti-CD3/CD28 (1ug/mL) supplemented with 
100IU/mL IL2. For experiments with P14 CD8+ T cells, bulk splenocytes were activated 
with gp33 peptide (1ug/mL) as previously described (Lin et al., 2016). For experiments 
with switched memory B cells, CD23+, IgD-, IgM-, lineage negative (CD4, CD8, Gr1) 
cells were first sorted from bulk splenocytes and then stimulated with LPS (20ug/mL). In 
all experiments, lymphocytes were labeled with Cell Trace Violet (CTV) prior to 
stimulation according to the manufacturer’s instructions to monitor cell division number. 
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Where indicated, cells were treated with the following drugs: Ly294002 (Cell Signaling 
Technology, used at 2.5-5uM), Blebbistatin (Abcam, used at 20uM).  
 
In vivo infection  
For in vivo experiments of CD8+ T cell differentiation, 1-3x10^6 TCF7-GFP reporter P14 
CD8+ T cells were adoptively transferred intravenously (i.v.) into allotype-disparate 
C57Bl/6 wild-type mice, which were subsequently infected with 5x10^3 CFUs of L. 
monocytogenes expressing gp33 (LM-gp33) via i.v. injection. Spleens were harvested 
at day 4-5 of infection, and CD8+ T cells were then MACS enriched for cell sorting of 
transferred, TCF7-GFP+ P14 cells. For experiments on tissue homing of Th1 CD4+ T 
cells, 1-3x10^6 OT-II Thy1.1+ CD4 T cells were purified, pulse-labeled with CTV and 
MitoTracker Green FM, and then adoptively transferred into Thy1.2+ recipients 24 hr 




Single-cell suspensions were prepared and stained as previously described (Lin Cell 
Reports 2016). For staining of transcription factors, the eBioscience Foxp3 kit was used. 
Antibodies used in this study include: rabbit anti-myc tag (71D10, Cell Signaling 
Technology), mouse anti-myc tag (4A6, Millipore), TCF1 (C63D9, Cell Signaling 
Technology), Pax5 (1H9, eBioscience), IgM (Il/41, eBioscience), IgD, (11-26c.2a), CD23 
(B3B4, eBioscience), CD4 (RM405, Biolegend), CD8a (53-6.7, eBioscience), Gr1 (RB6-
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8C5, BD Pharmingen). BD LSRII and Fortessa flow cytometers were used to analyze 
cells. Data were analyzed using FlowJo software (Tree Star). 
 
Confocal Microscopy 
Immunofluorescence microscopy of mitotic B and T cells was performed as previously 
described (Lin et al., 2015). Briefly, cells were adhered to poly-l-lysine (Sigma) coated 
coverslips and fixed with 3.7% paraformaldehyde followed by permeablization with 0.3% 
Triton X-100. Cells were then blocked in buffer containing 0.01% saponin and 0.25% 
fish skin gelatin (Sigma) in PBS+ and stained with antibodies to the indicated proteins. 
Antibodies used include: a-tubulin (YOL1/34, Abcam), b-tubulin (AA2, Sigma), CD19 
(1D3, BD Pharmingen), IgM (II/41, eBioscience), PIP3 (RC6F8, Thermo Fischer), Glut1 
(EPR3915, Abcam), anti-CD3e chain (ebio500A2, eBioscience), goat anti-mouse-IgM 
(Thermo Fischer). All Alexa Fluor dye-conjugated secondary antibodies were obtained 
from Thermo Fischer. Imaging was performed on Nikon Ti-Eclipse inverted scanning 
confocal or spinning disk confocal microscopes. Images were processed with ImageJ 
software. Metaphase cells were identified by the presence of two microtubule organizing 
centers (MTOC) with opposed spindle poles. Late telophase/cytokinetic cells were 
identified by the presence of a characteristic tubulin bridge and cytoplasmic cleft. To 
quantify polarity in interphase cells, a decentralization score was calculated based on 
the proximity of fluorescent puncta to the microtubule organizing center. Cells were 
divided into 6 equal quadrants, and each quadrant that contained at least 1 fluorescent 
puncta was counted toward the decentralization score. The quadrant containing the 
MTOC was worth 0 points, the two adjacent quadrants 1 point each, the two further 
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quadrants 2 points each, and the quadrant directly opposite the MTOC 3 points. Cells 
with fluorescent puncta entirely localized to the MTOC quadrant therefore received a 
score of 0 (the most polarized score) while cells with dispersed/decentralized puncta 
had higher scores. For quantification of asymmetry in mitotic cells, fluorescent signal 
was thresholded to remove background, and the integrated fluorescence density in 
each nascent daughter cell or half of the metaphase plate was calculated. Asymmetry 
was calculated as (fluorescence daughter 1 – fluorescence daughter 2) / (fluorescence 
daughter 1 + fluorescence daughter 2), with values over 0.2 considered asymmetric. 
Statistical significance was assessed using GraphPad Prism and specific statistical 
tests are indicated in each figure legend. 
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Chapter 4: Metabolic Control of Hematopoietic Progenitor Cell Fate Bifurcations 
Portions of this chapter have been adapted from the manuscript 
Kratchmarov R, Viragova S, Kim MJ, Rothman NJ, Liu K, Reizis B, and Reiner, SL. 
(2017). Metabolic control of cell fate bifurcations in a hematopoietic progenitor 





Growth signals drive hematopoietic progenitor cells to proliferate and branch into 
divergent cell fates, but how unequal outcomes arise from a common progenitor is not 
fully understood. We used steady-state analysis of in vivo hematopoiesis and Flt3L-
induced in vitro differentiation of DCs to understand how growth signals regulate lineage 
bias. We found that cDC1 versus cDC2 development is characterized by tempered 
versus unrestrained anabolic metabolism, respectively. Perturbation of AMPK signaling, 
fatty acid oxidation, or mitochondrial clearance each increased development of cDC2 
cells at the expense of cDC1 cells. Conversely, scavenging reactive oxygen species 
skewed differentiation towards cDC1 cells. Sibling cells of dividing DC progenitors were 
found to express unequal abundance of the transcription factor IRF8. Retention of IRF8 
expression in one of two sibling cells correlated with FoxO3a activity. Unequal 
transmission of growth signals during cell division may explain how metabolism 






Hematopoietic progenitor cells undergo spatially and temporally regulated differentiation 
programs to populate the mature blood lineages. Developmental programs are 
modulated by external stimuli, including infection and cancer, as well as intrinsic, 
homeostatic patterns of cell turnover. During cellular differentiation, multi-potent 
progenitor cells undergo progressive specification into divergent lineages (Pei et al., 
2017).  
Dendritic cells (DCs) are sentinel immune cells that develop from hematopoietic 
progenitors and are found in functionally distinct subsets, including cDC1, cDC2, and 
plasmacytoid dendritic cells (pDC) with distinct transcriptional programs. The 
developmental pathway of DCs has been defined in both mouse and human, but the 
mechanisms underlying these developmental cell fate bifurcations are unresolved 
(Murphy et al., 2016). 
Signaling through the Flt3 receptor (Flt3R/CD135) initiates DC differentiation and 
interferon regulatory factor (IRF)-8 expression to extinguish neutrophil lineage potential 
(Becker et al., 2012; Kurotaki et al., 2014). IRF8 expression is maintained across DC 
progenitors until terminal differentiation in the peripheral lymphoid tissue (Liu et al., 
2009; Naik et al., 2006), though there is evidence for preliminary specification of cDC1 
vs. cDC2 fate in the BM (Schlitzer et al., 2015). In mature DCs, IRF8 is differentially 
required for the maintenance/function of certain subsets, and cDC1/cDC2s employ 
divergent transcriptional programs (Sichien et al., 2016). IRF8 and Batf3 direct cDC1 
DC differentiation (Grajales-Reyes et al., 2015; Hildner et al., 2008), while tissue-
specific transcription factors specify cDC2s (Tussiwand et al., 2015; Vander Lugt et al., 
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2014). pDC development is dependent on E2-2 and IRF8 (Cisse et al., 2008). 
Conversely, FOXO3a restrains terminal differentiation of DC progenitors (Dejean et al., 
2009). 
Flt3L signaling activates the mTORC pathway (Sathaliyawala et al., 2010; Wang 
et al., 2013), and PI3K/mTOR as well as their associated regulator subunits may have 
tissue-specific roles in DC development (Nobs et al., 2015; Scheffler et al., 2014; 
Sinclair et al., 2017). Emerging evidence implicates the metabolic state of hematopoietic 
cells as a determinant of cell fate (Chandel et al., 2016; Ito and Ito, 2016). Whether 
stochastic or deterministic changes in transcription factor expression underlie progenitor 
cell fate decisions remains unresolved (Hoppe et al., 2016). Asymmetric cell division 
may regulate stem cell differentiation and enables a cell to generate distinct progeny 
that either remain quiescent or undergo terminal differentiation (Morrison and Kimble, 
2006). Here we examined the role of metabolic signaling in DC progenitor cell 
differentiation. Our findings are consistent with a model wherein activated progenitors 
undergo an anabolic switch that is coupled to cell division and asymmetric transcription 










Division-linked differentiation and IRF8 heterogeneity of DC progenitors 
We assessed the dynamics of IRF8 expression and DC differentiation through a well-
characterized in vitro system in which BM hematopoietic progenitor cells cultured in 
Flt3L undergo differentiation into cDC1-like, cDC2-like, and pDC-like subsets (Naik et 
al., 2005). Flt3L induced proliferation of progenitors, with upregulation of CD11c, a 
marker of the DC lineage, occurring after multiple divisions (Figure 4.1A). After 7-9 days 
in culture, three DC subsets defined by MHCII and B220 expression could be 
differentiated, including cDCs (CD11c+ MHCII+ B220-), pDCs (CD11c+ MHCII-lo/int 
B220+) and immature pre-DCs (CD11c+ MHCII- B220-) (Figure 4.1A). Within the cDC 
compartment, two subsets with reciprocal expression of the transcription factors IRF8 
and IRF4 were observed (Figure 4.1B). Surface marker expression, including CD24, 
Sirp1α, and CD11b, confirmed that the IRF8-high and IRF4-high subsets respectively 
resembled cDC1 and cDC2 cells. We then assessed the expression of IRF8 in relation 
to cell division at day 3, 6, and 9 of culture (Figure 4.1C). Expression of IRF8 was 
heterogeneous, with three distinct populations, IRF8-hi, IRF8-int, and IRF8-lo detectable 
by day 5 in culture. These populations then resolved to an IRF8hi and low state 
concomitant with DC maturation. Thus, Flt3L signaling induces cell division in DC 
progenitors, and terminal DC development with IRF8 heterogeneity is coupled to 
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Figure 4.1 Cytokine-induced DC developmental branching 














Figure 4.1 Cytokine-induced DC developmental branching 
accompanying progenitor cell expansion. (A) Expression of CD11c 
versus cell division at day 3, 6, and 9 of culture. Right: cDC (CD11c+ 
MHCII+) and pDC (CD11c+ B220+ MHCII-) subsets among CD11c+ cells 
at day 9. Statistic indicates mean +/- standard error the mean (SEM) for 
gate. (B) Left: Expression of IRF8 and IRF4 marks distinct cDC1 and 
cDC2 subsets. Statistic indicates mean +/- SEM for gate. Right: 
Representative histograms of expression of surface markers CD24, 
Sirp1-α, and CD11b by IRF8-high and IRF4-high cDCs. Histograms are 
representative of at least 5 independent experiments. (C) Heterogeneity 
of IRF8 expression by cell division at day 3, 6, and 9 of culture. 
Representative FACS plots from three independent experiments showing 
IRF8-low, IRF8-int, and IRF8-high populations at day 3, IRF8-int and 
IRF8-high at day 6, and IRF8-low and IRF8-high at day 9. (D) Flt3L 
stimulation increases anabolic signaling in DC progenitors. Left: 
Representative histogram of CTV dye dilution for gating of undivided and 
proliferating progenitor cells. Right: Representative histograms and 
quantification of forward scatter (FSC), an index of cell size, and nutrient 
transporter expression (CD98, CD71, and Glut1) by proliferating (grey fill) 
and undivided (black line) progenitors at day 3 of culture. *p<0.05. 
**p<0.01. ***p<0.001. Student’s T test. (E) Glycolysis is required for Flt3L-
induced DC progenitor cell proliferation. Left: Increased glucose uptake in 
proliferating DC progenitors. **p<0.01. Student’s T test. Right: Cell 
division with increasing concentrations of glycolysis inhibitor 2-DG. Plots 
are representative of 3 independent experiments.
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Flt3L induces an anabolic switch in DC progenitors 
Flt3L signaling activates PI3K/Akt/mTOR (Nobs et al., 2015; Sathaliyawala et al., 2010), 
and negative regulation of mTOR by Tsc1 is important for regulated DC development 
(Wang et al., 2013). We asked whether the bifurcating cell fate trajectories of IRF8-hi 
and IRF4-hi DCs are coupled to a metabolic switch during terminal differentiation. 
Progenitor cells that had undergone cell division showed a marked increase in size as 
well as increased expression of CD71, the transferrin receptor, CD98, an amino acid 
transporter, and Glut1, an Akt-regulated, inducible glucose transporter (Wieman et al., 
2007) (Figure 4.1D). These results suggest that terminal differentiation is associated 
with anabolic activation of progenitor cells.  
 We then asked whether pharmacologic perturbation of nutritive signaling could 
alter DC development. Progenitor cells increased glucose uptake following Flt3L 
stimulation (Figure 4.1E). 2-DG, an irreversible inhibitor of glycolysis, inhibited Flt3L-
induced proliferation in a dose-dependent fashion (Figure 4.1E), suggesting that 
glycolysis is essential for DC progenitor differentiation. We next determined whether 
fatty acid oxidation, a key regulator of stem cell self-renewal (Ito et al., 2012), was 
important for progenitor cell fate. Inhibition of fatty acid oxidation with the Cpt1 inhibitor 
etomoxir did not affect cDC/pDC development but significantly increased the 
differentiation of IRF4+ cDC2s (Figure 4.2A). These results indicate that the balance of 






















































































































Figure 4.2 Mitochondrial dynamics and metabolism 










































































































Figure 4.2 Mitochondrial dynamics and metabolism promote 
selective DC differentiation. (A) Fatty acid oxidation modulates cDC 
subset development. Left: Frequency of cDC and pDCs amongst 
CD11c+ DCs following etomoxir treatment. n.s. not significant. 
Student’s T test with Holm-Sidak correction. Right: Development of 
IRF8+ and IRF4+ DC subsets in cultures treated with etomoxir. 
**p<0.01. Paired T test. (B) Mitoclearance assay. Progenitors were 
pulse-labeled with MTGreen at early (day 0) and late (day 4) time 
points of culture and assessed for decay of fluorescence 3 days later. 
FACS plots show decaying MTGreen fluorescence per cell division 
with or without mDivi-1 treatment. Trapezoid gate denotes MTGreen-
low population. Plots are representative of 3 independent 
experiments. (C) Left: Frequency of cDC and pDCs amongst CD11c+ 
DCs following mDivi-1 or M1 treatment. *p<0.05. n.s. not significant. 
Student’s T test with Holm-Sidak correction. Right: Frequency of 
IRF8+ and IRF4+ cDC subsets following treatment with mDivi-1 
(upper) or M1 (lower). **p<0.01. ***p<0.001. Paired T test. (D) Flt3L 
induces mROS production in proliferating progenitors. Left: MitoSox
levels versus cell division at day 3 of culture in IRF8-int and IRF8-high 
progenitors. Right: Quantification of MitoSox MFI in IRF8-int and 
IRF8-high cells. **** p<0.0001. Student’s T test. (E) Left: Frequency of 
cDC and pDCs amongst CD11c+ DCs following treatment with N-Ac. 
n.s. not significant. Student’s T test with Holm-Sidak correction. Right: 
Frequency of IRF8+ and IRF4+ cDC subsets following treatment with 
N-Ac. *p<0.05. Paired T test.
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Mitochondrial dynamics during DC progenitor differentiation 
Changes in mitochondrial function are crucial for supporting the bioenergetic demands 
of different cell fates, and mitochondria are important for lymphoid/myeloid progenitor 
cell balance (Luchsinger et al., 2016). Mitophagy is also critical for maintaining self-
renewal in hematopoietic stem cells (Ho et al., 2017; Ito et al., 2016). As such, we 
asked whether mitochondrial function and turnover modulate Flt3L-induced homeostatic 
DC development. We first assayed mitochondrial clearance at early and late time points 
following Flt3L stimulation with a fluorescence based pulse-chase assay (Adams et al., 
2016). Total mitochondria in progenitors were labeled with Mitotracker dye, and 
fluorescence was then quantified at day 3 post-activation. Aged mitochondria were 
passively cleared as well as degraded following Flt3L stimulation (Figure 4.2B). This 
degradation was dependent on mitochondrial fission, as treatment of cultures with the 
Drp1 inhibitor mDivi-1 (Cassidy-Stone et al., 2008) resulted in stasis of aged 
mitochondria across cell divisions (Figure 4.2B). This pattern of mitochondrial clearance 
was also observed when organelles were pulse labeled at day 4 of culture and then 
quantified at day 7 (Figure 4.2B). We then assessed whether mitochondrial dynamics 
and turnover are important for cDC1 vs. cDC2 differentiation. Treatment with m-Divi1, or 
M1, a mitochondrial fusion promoter (Buck et al., 2016; Wang et al., 2012), did not have 
significant effects on overall cDC/pDC development but promoted IRF4+ cDC2 
differentiation (Figure 4.2C). These results suggest that the clearance of old 
mitochondria and/or the balance of fission/fusion are important for DC subset 
specification. 
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Mitochondria function as signaling organelles during development and 
homeostasis through the production of mROS (Chandel, 2015). mROS increases PI3K 
activity and promotes terminal differentiation of hematopoietic progenitor cells and 
lymphocytes (Chen et al., 2008; Yalcin et al., 2010). We found that Flt3L stimulation of 
BM progenitors induced mROS production, with cells undergoing division exhibiting 
elevated, heterogeneous levels with a bimodal distribution (Figure 4.2D). We then 
determined whether IRF8 expression correlates with mROS production. Progenitor cells 
from IRF8-eGFP reporter mice were stimulated with Flt3L and labeled with MitoSox. 
IRF8-int cells exhibited higher levels of mROS (Figure 4.2D). We therefore assessed 
whether scavenging of mROS could alter the development of DC subsets. When 
cultures were treated with N-acetyl cysteine (N-Ac), a generalized scavenger of ROS, 
an increase in IRF8+ cDC1 development was observed (Figure 4.2E). These results 
suggest that DC progenitor differentiation involves unequal production of mROS and 
that perturbation of mROS levels can skew subset development. 
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AMPK-α1 promotes cDC1 differentiation 
To determine whether nutritive signaling drives progenitor cell fate bifurcations, we 
assessed the role of AMPK, an energy sensor that regulates self-renewal in 
hematopoietic stem cells and lymphocytes (Adams et al., 2016; Blagih et al., 2015; 
Nakada et al., 2010). We found that Flt3L induces AMPK signaling in BM progenitors 
(Figure 4.3A). Amongst proliferating cells, a population with phosphorylated, active 
AMPK was observed as well as phosphorylated acetyl-CoA carboxylase (ACC) and 
Raptor, key targets of AMPK. To determine whether AMPK is required for 
differentiation, we assessed the development of cDC1/cDC2 from AMPK-α1 knockout 
progenitors. AMPK-α1 deficiency resulted in a modest decrease in the total number of 
CD11c+ cells generated (Figure 4.3B). Within the cDC compartment, we observed a 
significant increase in IRF4+ cDC2 development from AMPK-α1 deficient progenitors. 
Loss of AMPK signaling was synergist with inhibition of mitochondrial fission, resulting 
in a severe loss of IRF8+ cDC1 development (Figure 4.3B). We then determined 
whether AMPK-α1 was required for regulated cDC1/cDC2 development in vivo (Figure 
4.3C). While no differences in bone marrow DC progenitor frequencies were observed, 
we found that AMPK-α1 was required for efficient terminal cDC1 differentiation in vivo 
(Figure 4.3C). In skin-draining lymph nodes, proportions of cDC/pDC were unaffected 
by loss of AMPK-α1. Resident CD8a+ cDC1s were, however, significantly reduced in 
AMPK-α1 deficient animals, alongside a lesser reduction in migratory CD8a- CD11b- 
DCs. Conversely, we observed an increase in CD11b+ cDC2 cells. Thus, catabolic 
signaling mediated by AMPK-α1 may be involved in DC progenitor cell fate bifurcations 




















AMPK-   1(-/-) KO















































































































AMPK-   1(+/-) WT
AMPK-   1 KO
AMPK-   1 KO
AMPK-   1 KO + mDivi1




Figure 4.3 Nutrient sensor AMPK promotes 
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Figure 4.3 Nutrient sensor AMPK promotes selective DC differentiation. 
(A) Flt3L induces AMPK signaling. Representative histograms of pAMPK, 
pACC, and pRaptor in proliferating (black line) and undivided (grey fill) 
progenitor cells stimulated with Flt3L for 3 days. Plots are representative of 
2-3 independent experiments. (B) AMPK-α1 deficiency alters DC 
development in vitro. Left: Development of total CD11c+ cells, and 
cDC/pDCs from AMPK-α1 deficient cells and heterozygote littermate (“WT”) 
controls. n.s. not significant. Student’s T test with Holm-Sidak correction. 
Right: differentiation of IRF8+ and IRF4+ cDC subsets from AMPK-α1 
deficient progenitors with or without mDivi-1 treatment. *p<0.05 **p<0.01 
***p<0.001. Repeated measures one way ANOVA with Tukey’s correction for 
multiple comparisons. (C) Steady state in vivo bone marrow DC progenitor 
(upper row), as well as skin draining lymph node cDC/pDC and cDC subset 
(lower row) frequencies of AMPK-α1 knockout mice and heterozygote 
littermate (WT) controls. In bone marrow, DC progenitors were gated as 
lineage (CD3, CD19, B220, NK1.1, Ter119, GR1, CD11b) negative, Flt3R 
(CD135)+, CX3CR1+ cells. Macrophage dendritic cell progenitors (MDP) 
were c-kit+ CD11c-. Common dendritic progenitors (CDP) were c-kit- CD11c-
. Pre-DCs were c-kit- CD11c+. In lymph nodes, pDCs were lineage- CD11c+ 
MHCII-int B220+, and amongst lineage- CD11c+ MHCII+ B220- mature 
cDCs, cDC1 were gated as CD8a+ CD11b-, migratory DCs were CD8a-
CD11b-, and cDC2 were CD8a- CD11b+. *p<0.05. ***p<0.001. n.s. not 
significant. Paired T test. 
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Asymmetric division of IRF8 in DC progenitors 
Hematopoietic progenitor cells can undergo both asymmetric and symmetric divisions 
(Wu et al., 2007). The pattern of IRF8 transcriptional heterogeneity during DC 
development suggested that these cell fate bifurcations could be linked to cell division. 
We therefore assessed the localization of IRF8 in interphase and mitotic cells by 
immunofluorescence microscopy (Figure 4.4A). In interphase, we observed varying 
levels of IRF8 expression with a predominantly nuclear localization pattern. During the 
early stages of mitosis, i.e. prophase/metaphase/anaphase, IRF8 was excluded from 
condensed chromatin and exhibited a diffuse and symmetric localization (Figure 4.4A). 
However, robust asymmetry of IRF8 was observed in conjoined daughter cells 
undergoing cytokinesis. Asymmetry of transcription factors during late cytokinesis 
suggests that asymmetric signaling may occur during mitosis, as in lymphocytes 
(Adams et al., 2016; Lin et al., 2015; Pollizzi et al., 2016; Verbist et al., 2016).  
The observed effects of metabolic perturbations on DC progenitor differentiation 
are consistent with a model in which opposing PI3K/AMPK signals modulate cell fate 
bifurcation. Crosstalk with AMPK regulates FOXO3a transcriptional activity, and 
FOXO3a conditional knockout mice have increased DC development, with the largest 
effect on cDC2s (Dejean et al., 2009). FOXO3a has also been implicated in the 
regulation of mitochondrial function in HSCs (Rimmelé et al., 2015). We found that Flt3L 
signaling induces phosphorylation of FOXO3a (Figure 4.4B). We then tested whether 
FOXO3a activity was important for regulating DC subset development. Pharmacologic 
inhibition of FOXO1/3a resulted in a substantial increase in pDC development with a 
concomitant decrease in the numbers of cDCs (Figure 4.4B). We examined the 
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localization and inheritance of FOXO3a in mitotic DC progenitors where both nuclear 
and cytoplasmic localizations patterns were observed. FOXO3a protein levels were also 
frequently asymmetric though the magnitude of asymmetry was markedly lower than for 
IRF8 (Figure 4.4C). Amongst IRF8 asymmetric sibling cell pairs, FOXO3a activity was 
asymmetric, with nuclear FOXO3a protein predominantly inherited by the IRF8-high 
daughter. Thus, FOXO3a regulates DC progenitor cell differentiation and exhibits 


















Figure 4.4 Asymmetric division of DC progenitors 































































































Figure 4.4 Asymmetric division of DC progenitors supporting 
developmental branching. (a) Localization and inheritance of IRF8 in 
progenitors at day 4-5 of culture with Flt3L. IRF8+ CD11c+ cells were 
FACS sorted for immunofluorescence (IF) microscopy analysis. Upper: 
Localization of IRF8 in interphase cells. Middle and lower: Localization of 
IRF8 in early (metaphase/anaphase) and late (cytokinesis) mitotic cells 
Left: Representative IF images of IRF8, tubulin, and DNA. Right: 
Quantification of IRF8 asymmetry ratio as well as % asymmetric cells, as 
described in methods. *** p<0.001. n.s. not significant. Fisher’s Exact 
Test. Scale bar 5uM. (b) Left: Flt3L induces phosphorylation of FoxO1/3a. 
Representative histograms and quantification of p-FoxO1/3a in IRF8-high 
progenitors stimulated with Flt3L overnight or rested without cytokine. 
*p<0.05. Paired T test. Right: FOXO inhibitor AS1842856 increases pDC 
development. Bar graphs indicate frequency of each subset +/- SEM. 
***p<0.001 Student’s T test with Holm-Sidak correction. (c) Nuclear 
FoxO3a localization in IRF8hi daughter cells. Upper: Representative IF 
images of IRF8, tubulin, DNA, and transmitted light in conjoined sibling 
cells. Lower Left: Quantification of IRF8, FoxO3a, and DNA asymmetry 
and % asymmetric cells amongst cytokinetic cells. ***p<0.001 
****p<0.0001. Fisher’s Exact Test. Lower Right: Amongst IRF8-
asymmetric cytokinetic cells, proportion of IRF8-high daughters with 




Emerging evidence indicates that metabolic signaling is coupled to cell fate 
bifurcations via the action of key transcription factors. These metabolic signals are 
organized into constellations that exhibit feed-back and feed-forward characteristics to 
ensure fidelity in cell fate decisions. Perturbation of one element of the constellation, 
e.g. mitochondrial quality control or ROS production, can induce downstream and 
upstream effects on the system due to synergy of the individual elements. Here, we 
should that metabolic signals from anabolic and catabolic pathways can direct specific 
DC development. Progenitor cells undergoing terminal differentiation following Flt3L 
signaling diverge in fate due to the effects of growth factor signaling on metabolic 
pathways and transcription factor expression. Reciprocal expression of IRF8 has been 
linked to bifurcating cell fates in activated lymphocytes (Xu et al., 2015a), and our work 
suggests that progenitor cell fate bifurcations across different modes of pattern 
formation may involve a generalizable mechanism of asymmetric division coupled to 
unequal nutritive signaling. Asymmetry of IRF8 could promote terminal bifurcations as 
well as earlier lineage biasing of more primitive progenitor cells (Lee et al., 2017).  
These results have implications for understanding the detrimental changes in 
hematopoiesis that accompany aging, malignancy, and infection, and suggest avenues 








All animal work was conducted in accordance with the Institutional Animal Care and 
Use Guidelines of Columbia University. Mice were housed in specific-pathogen-free 
conditions. Both male and female mice were used, and mice were between 6-8 weeks 
of age. C57BL/6 wild type, IRF8-eGFP reporter (Wang et al., 2014), and AMPK-α1 
knockout mice (Jørgensen et al., 2004) were used. Spleens, skin-draining lymph nodes, 
and long bones were harvested based on experimental needs.  
 
DC Differentiation Assay and Drug Treatments 
BM progenitors were cultured in RPMI 1640 supplemented with 10% FBS, 1% 
penicillin/streptomycin, and human recombinant Flt3L (Celldex or Peprotech) at 
100ng/mL to induce DC development. Drugs used for pharmacologic perturbation of DC 
development were all added at the beginning of culture and included: mDivi-1 (Cayman, 
used at 10uM), M1 (Sigma, used at 5uM), FoxO1/3a inhibitor (AS1842856; Calbiochem, 
used at 1uM), N-Acetyl cysteine (N-Ac, Sigma, used at 5mM), 2-deoxyglucose (2-DG, 
Sigma, used at 100uM-1mM), and etomoxir (Cayman, used at 100uM).  
 
Flow Cytometry 
Staining for flow cytometry analysis was performed as described (3, 4). Antibodies used 
in this study include: B220 (RA3-6B2, eBioscience), MHCII (M5/114.15.2, Biolegend 
and Tonbo Biosciences), CD3 (2C11, BD Pharmingen), CD8a (53-6.7, Biolegend), 
CD11b (M1/70, Biolegend), CD11c (N418, Biolegend), CD19 (1D3, BD Pharmingen), 
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CD24 (M1/69, Biolegend), CD71 (RI7217, Biolegend), CD98 (Rl388; Biolegend), CD117 
(c-Kit, 2B8, eBioscience), CD135 (Flt3R, A2F10, eBioscience), Glut1 (EPR3915; 
Abcam), phospho-S6 (S235/236; Cell Signaling Technology), p-AMPK (40H9, Cell 
Signaling Technology), p-ACC (D7D11, Cell Signaling Technology),  phospho-
FOXO1/3a (9464; Cell Signaling Technology), p-Raptor (24C12, Cell Signaling 
Technology), IRF8 (V3GYWCH, eBioscience), IRF4 (3E4, eBioscience), Gr1 (RB6-8C5, 
BD Pharmingen), Nk1.1 (PK136, Biolegend), Ter119 (TER-119, BD Pharmingen), and 
goat anti-rabbit Alexa Fluor 647 secondary (Thermo Fischer). Samples were acquired 
on a BD LSRII or BD Fortessa, and analysis was performed with FlowJo software 
(Treestar, San Carlos, CA). Glucose uptake was measured by incubating cells in 2-
NBDG (Cayman; 100 μM) for 45 minutes at 37 °C in glucose free RPMI supplemented 
with 10% dialyzed FBS. Mitoclearance was assessed by labeling progenitor cells with 
Mitotracker Green (Thermo Fisher; 200nM per 1x10^6 cells) followed by two washes 
with complete media. Cells were then labeled with Cell Trace Violet according to the 
manufacturer’s instructions (CTV, Thermo Fischer). Mitochondrial ROS was detected by 




Immunofluorescence microscopy was performed as previously described (Lin et al., 
2015). Antibodies used include: α-tubulin (YOL1/34, Abcam), β-tubulin (AA2, Sigma), 
IRF8 (V3GYWCH, eBioscience), and FOXO3a (75D8, Cell Signaling Technology). 
Alexa Fluor dye-conjugated secondary antibodies (Thermo Fischer) were used at 
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1:1000. All imaging was performed on Nikon Ti-Eclipse inverted scanning or spinning 
disk confocal microscopes. Images were processed with ImageJ software. Metaphase 
cells were identified by the presence of two microtubule organizing centers (MTOC) with 
opposed spindle poles. Nascent cytokinetic daughter cell pairs were identified by their 
residual connection, i.e. the tubulin bridge and cytoplasmic cleft. For quantification of 
asymmetry in mitotic cells, fluorescent signal was thresholded to remove background, 
and the integrated fluorescence density in each nascent daughter cell or half of the 
metaphase plate was calculated. Asymmetry was calculated as (fluorescence daughter 
1 – fluorescence daughter 2) / (fluorescence daughter 1 + fluorescence daughter 2), 
with values over 0.2 considered asymmetric.  
 
Statistical analyses 
Statistical analyses were performed using GraphPad Prism (version 6). P-values and 












Conclusions and Future Directions 
 
While it has been previously established that distinct types of metabolism are required 
for the function of mature cells (Buck et al., 2017), our results establish metabolic 
signals as a critical node for regulating the differentiation and cell fate of progenitors in 
the immune and hematopoietic systems. Preserving the fidelity of lineage trees in the 
hematopoietic system as well as effector versus memory cell fate decisions in 
lymphocytes is critical for maintain homeostasis in the context of cellular turnover. By 
connecting metabolism with cell fate through the action of key transcription factors, self-
renewal is ensured through a feed-forward feed-back mechanism that dampens 
activation/differentiation in certain progeny. Our results may explain the observed 
deficiencies in self-renewal observed during chronic infections and cancer, wherein 
excessive terminal effector cell differentiation precipitates the collapse of protective 
immunity.  
 Further work will be necessary to characterize the intracellular pathway that 
facilitates asymmetric metabolic signaling. Our results suggest that polarized traffic of 
endocytosed membranes as well as intracellular organelles can direct the asymmetric 
division of cells, with important functional consequences including the asymmetric 
expression of fate determining transcription factors occurring downstream. The 
trafficking of these subcellular compartments may be independent of the PAR polarity 
network (Emery et al., 2005), potentially explaining the modest phenotypes observed in 
both lymphocytes and hematopoietic cells for PAR knockout mice (Nish et al., 2017a). 
The asymmetry of Rab11 recycling endosomes has been described previously (Emery 
et al., 2005), and it will be important to establish whether the asymmetry pathway 
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described here involves Rab11+ structures. Of note, Class II PI3K activity has been 
implicated in endosomal trafficking and recycling (Marat and Haucke, 2016) and may 
explain why inhibition of Class I PI3K does not fully abolish mitotic asymmetry. 
Perturbation of the recycling endosome pathway with dominant negative Rab11 
constructs will clarify the contribution of these vesicles to the asymmetric division of 
lymphocytes.  
The observation that this asymmetry pathway is functional in cells activated by 
soluble stimuli, i.e. LPS, as well as cells no longer receiving antigen receptor 
stimulation, i.e. sorted T cells, raises a critical question regarding the initiating receptor 
or protein that organizes the subsequent cascade of polarized signals. It is possible that 
PI3K activity may self-aggregate, particularly in the context of lipid raft microdomains 
which have been implicated in the clustering of antigen receptor signaling scaffolds 
(Sezgin et al., 2017). Alternatively, the existence of homotypic T-T cell and B-B cell 
synapses has been described, and it is possible that direct contact between 
lymphocytes subsequent to initial activation by an APC may be sufficient to drive 
polarity of the observed factors (Gérard et al., 2013; Severinson and Westerberg, 2003). 
The ability to modulate cell fate bifurcations via metabolic perturbations presents 
an attractive avenue for therapeutic intervention during infection, cancer, and aging. Key 
pharmacologic agents that alter cellular metabolic pathways, including the mTOR 
inhibitor rapamycin, AMPK agonist metformin, and PI3K inhibitor idelalisib, are all FDA 
approved for the treatment of other conditions and have manageable side-effect 
profiles. Metformin, in particular, is taken regularly by large portions of the general 
population and has minimal side-effects; it will be critical to determine its effects on 
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immune function. Several studies have already demonstrated the feasibility of 
combining checkpoint blockade with drugs targeting metabolic pathways in mouse 
models of cancer (Bowers et al., 2017; Pedicord et al., 2015). This body of work 
supports the idea that maintaining progenitor cell function could improve outcomes for 
the treatment of conditions that strain the regenerative capacity of the immune system. 
Similarly, it is well-known that the aging hematopoietic system becomes myeloid-biased, 
with alterations in the lymphoid-biased progenitor compartment (Dykstra et al., 2011; 
Pang et al., 2011; Snoeck, 2013). It is possible that altering the metabolic signaling 
environment within certain bone marrow niches may be sufficient to redirect key 
progenitor populations and restore the balance of differentiation programs. Scavenging 
of ROS, which are known to modulate PI3K activity in progenitors, presents a candidate 
pharmacological intervention. 
 The successful metabolic intervention on immune and hematopoietic cells is 
partially predicated on the assumption that deterministic differentiation programs govern 
the dynamics of these cells. If key inflection points govern the bifurcation of 
effector/memory cells, then it is formally possible to alter the balance of these decisions 
via extrinsic modulation of the signaling pathways that underlie each branch point. 
However, if stochastic differentiation and competition underlie the acquisition of distinct 
cell fates, it is more difficult to predict the effect of extrinsic perturbations on the 
outcome of the system. Unambiguous resolution of the question of deterministic versus 
stochastic differentiation will therefore be critical for informing the design of next 
generation therapies. Advances in cellular barcoding techniques that render such 
assays more tractable and reproducible may facilitate such advances (Pei et al., 2017), 
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as current technologies present major barriers to entry. Improvements in live cell 
imaging systems as well as in situ imaging techniques via two-photon microscopy will 
also be critical for studying the immune response in vivo. The application of such 
techniques to mouse models of lymphocyte differentiation can clarify the contribution of 
asymmetric division to cell fate bifurcations. Nevertheless, it is possible that a 
combination of noise/stochastic differentiation and deterministic lineage trees more fully 
describe the behavior of such cells than more constrained individual models. A 
combination of improved mouse experimentation as well as proof-of-concept studies in 
humans will ultimately drive the improvement of immunotherapies for currently 
intractable conditions.  
 104 
References 
Adams, W.C., Chen, Y.-H., Kratchmarov, R., Bonnie, Y., Nish, S.A., Lin, W.-H.W., 
Rothman, N.J., Luchsinger, L.L., Klein, U., Busslinger, M., et al. (2016). Anabolism-
Associated Mitochondrial Stasis Driving Lymphocyte Differentiation over Self-Renewal. 
Cell Reports 17, 3142–3152. 
Arsenio, J., Kakaradov, B., Metz, P.J., Kim, S.H., Yeo, G.W., and Chang, J.T. (2014). 
Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by 
single-cell gene-expression analyses. Nat Immunol 15, 365–372. 
Becattini, S., Latorre, D., Mele, F., Foglierini, M., De Gregorio, C., Cassotta, A., 
Fernandez, B., Kelderman, S., Schumacher, T.N., Corti, D., et al. (2015). Functional 
heterogeneity of human memory CD4⁺ T cell clones primed by pathogens or vaccines. 
Science 347, 400–406. 
Becker, A.M., Michael, D.G., Satpathy, A.T., Sciammas, R., Singh, H., and 
Bhattacharya, D. (2012). IRF-8 extinguishes neutrophil production and promotes 
dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. 
Blood 119, 2003–2012. 
Blagih, J., Coulombe, F., Vincent, E.E., Dupuy, F., Galicia-Vázquez, G., Yurchenko, E., 
Raissi, T.C., van der Windt, G.J.W., Viollet, B., Pearce, E.L., et al. (2015). The energy 
sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. 
Immunity 42, 41–54. 
Bollig, N., Brüstle, A., Kellner, K., Ackermann, W., Abass, E., Raifer, H., Camara, B., 
Brendel, C., Giel, G., Bothur, E., et al. (2012). Transcription factor IRF4 determines 
germinal center formation through follicular T-helper cell differentiation. Proc. Natl. 
Acad. Sci. U.S.a. 109, 8664–8669. 
Bowers, J.S., Majchrzak, K., Nelson, M.H., Aksoy, B.A., Wyatt, M.M., Smith, A.S., 
Bailey, S.R., Neal, L.R., Hammerbacher, J.E., and Paulos, C.M. (2017). PI3Kδ Inhibition 
Enhances the Antitumor Fitness of Adoptively Transferred CD8(+) T Cells. Front 
Immunol 8, 1221. 
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., 
Mak, T.W., Kamradt, T., and Lohoff, M. (2007). The development of inflammatory T(H)-
17 cells requires interferon-regulatory factor 4. Nat Immunol 8, 958–966. 
Buchholz, V.R., Flossdorf, M., Hensel, I., Kretschmer, L., Weissbrich, B., Gräf, P., 
Verschoor, A., Schiemann, M., Höfer, T., and Busch, D.H. (2013). Disparate individual 
fates compose robust CD8+ T cell immunity. Science 340, 630–635. 
Buck, M.D., O'Sullivan, D., Klein Geltink, R.I., Curtis, J.D., Chang, C.-H., Sanin, D.E., 
Qiu, J., Kretz, O., Braas, D., van der Windt, G.J.W., et al. (2016). Mitochondrial 
Dynamics Controls T Cell Fate through Metabolic Programming. Cell 166, 63–76. 
 105 
Buck, M.D., Sowell, R.T., Kaech, S.M., and Pearce, E.L. (2017). Metabolic Instruction of 
Immunity. Cell 169, 570–586. 
Caro-Maldonado, A., Wang, R., Nichols, A.G., Kuraoka, M., Milasta, S., Sun, L.D., 
Gavin, A.L., Abel, E.D., Kelsoe, G., Green, D.R., et al. (2014). Metabolic reprogramming 
is required for antibody production that is suppressed in anergic but exaggerated in 
chronically BAFF-exposed B cells. J. Immunol. 192, 3626–3636. 
Cassidy-Stone, A., Chipuk, J.E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, 
M.J., Shaw, J.T., Hinshaw, J.E., Green, D.R., et al. (2008). Chemical inhibition of the 
mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial 
outer membrane permeabilization. Dev. Cell 14, 193–204. 
Chan, L.L.-Y., Shen, D., Wilkinson, A.R., Patton, W., Lai, N., Chan, E., Kuksin, D., Lin, 
B., and Qiu, J. (2012). A novel image-based cytometry method for autophagy detection 
in living cells. Autophagy 8, 1371–1382. 
Chandel, N.S. (2015). Evolution of Mitochondria as Signaling Organelles. Cell Metab. 
22, 204–206. 
Chandel, N.S., Jasper, H., Ho, T.T., and Passegué, E. (2016). Metabolic regulation of 
stem cell function in tissue homeostasis and organismal ageing. Nat. Cell Biol. 18, 823–
832. 
Chang, J.T., Ciocca, M.L., Kinjyo, I., Palanivel, V.R., McClurkin, C.E., Dejong, C.S., 
Mooney, E.C., Kim, J.S., Steinel, N.C., Oliaro, J., et al. (2011). Asymmetric proteasome 
segregation as a mechanism for unequal partitioning of the transcription factor T-bet 
during T lymphocyte division. Immunity 34, 492–504. 
Chang, J.T., Palanivel, V.R., Kinjyo, I., Schambach, F., Intlekofer, A.M., Banerjee, A., 
Longworth, S.A., Vinup, K.E., Mrass, P., Oliaro, J., et al. (2007). Asymmetric T 
lymphocyte division in the initiation of adaptive immune responses. Science 315, 1687–
1691. 
Chaturvedi, A., Martz, R., Dorward, D., Waisberg, M., and Pierce, S.K. (2011). 
Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from 
intracellular compartments. Nat Immunol 12, 1119–1126. 
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., and Zheng, P. (2008). TSC-
mTOR maintains quiescence and function of hematopoietic stem cells by repressing 
mitochondrial biogenesis and reactive oxygen species. Journal of Experimental 
Medicine 205, 2397–2408. 
Chen, M., Hong, M.J., Sun, H., Wang, L., Shi, X., Gilbert, B.E., Corry, D.B., 
Kheradmand, F., and Wang, J. (2014). Essential role for autophagy in the maintenance 
of immunological memory against influenza infection. Nat. Med. 20, 503–510. 
Choi, Y.S., Gullicksrud, J.A., Xing, S., Zeng, Z., Shan, Q., Li, F., Love, P.E., Peng, W., 
 106 
Xue, H.-H., and Crotty, S. (2015). LEF-1 and TCF-1 orchestrate T(FH) differentiation by 
regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat 
Immunol 16, 980–990. 
Cisse, B., Caton, M.L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., 
Zweier, C., Hollander, den, N.S., Kant, S.G., et al. (2008). Transcription factor E2-2 is 
an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 
37–48. 
Crotty, S., Johnston, R.J., and Schoenberger, S.P. (2010). Effectors and memories: Bcl-
6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 11, 114–120. 
Dainichi, T., Hayden, M.S., Park, S.-G., Oh, H., Seeley, J.J., Grinberg-Bleyer, Y., Beck, 
K.M., Miyachi, Y., Kabashima, K., Hashimoto, T., et al. (2016). PDK1 Is a Regulator of 
Epidermal Differentiation that Activates and Organizes Asymmetric Cell Division. Cell 
Reports 15, 1615–1623. 
Dejean, A.S., Beisner, D.R., Ch'en, I.L., Kerdiles, Y.M., Babour, A., Arden, K.C., 
Castrillon, D.H., DePinho, R.A., and Hedrick, S.M. (2009). Transcription factor Foxo3 
controls the magnitude of T cell immune responses by modulating the function of 
dendritic cells. Nat Immunol 10, 504–513. 
Dey-Guha, I., Wolfer, A., Yeh, A.C., G Albeck, J., Darp, R., Leon, E., Wulfkuhle, J., 
Petricoin, E.F., Wittner, B.S., and Ramaswamy, S. (2011). Asymmetric cancer cell 
division regulated by AKT. Proc. Natl. Acad. Sci. U.S.a. 108, 12845–12850. 
Doughty, C.A., Bleiman, B.F., Wagner, D.J., Dufort, F.J., Mataraza, J.M., Roberts, M.F., 
and Chiles, T.C. (2006). Antigen receptor-mediated changes in glucose metabolism in B 
lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of 
growth. Blood 107, 4458–4465. 
Duffy, K.R., Wellard, C.J., Markham, J.F., Zhou, J.H.S., Holmberg, R., Hawkins, E.D., 
Hasbold, J., Dowling, M.R., and Hodgkin, P.D. (2012). Activation-induced B cell fates 
are selected by intracellular stochastic competition. Science 335, 338–341. 
Dykstra, B., Olthof, S., Schreuder, J., Ritsema, M., and de Haan, G. (2011). Clonal 
analysis reveals multiple functional defects of aged murine hematopoietic stem cells. 
Journal of Experimental Medicine 208, 2691–2703. 
Eiyama, A., and Okamoto, K. (2015). PINK1/Parkin-mediated mitophagy in mammalian 
cells. Curr. Opin. Cell Biol. 33, 95–101. 
Emery, G., Hutterer, A., Berdnik, D., Mayer, B., Wirtz-Peitz, F., Gaitan, M.G., and 
Knoblich, J.A. (2005). Asymmetric Rab 11 endosomes regulate delta recycling and 
specify cell fate in the Drosophila nervous system. Cell 122, 763–773. 
Engelman, J.A., Luo, J., and Cantley, L.C. (2006). The evolution of phosphatidylinositol 
3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606–619. 
 107 
Fruman, D.A., Chiu, H., Hopkins, B.D., Bagrodia, S., Cantley, L.C., and Abraham, R.T. 
(2017). The PI3K Pathway in Human Disease. Cell 170, 605–635. 
Fuxa, M., and Busslinger, M. (2007). Reporter gene insertions reveal a strictly B 
lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J. 
Immunol. 178, 3031–3037. 
García-Prat, L., Martinez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., 
Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A.L., et al. (2016). 
Autophagy maintains stemness by preventing senescence. Nature 529, 37–42. 
Gerlach, C., Rohr, J.C., Perié, L., van Rooij, N., van Heijst, J.W.J., Velds, A., Urbanus, 
J., Naik, S.H., Jacobs, H., Beltman, J.B., et al. (2013). Heterogeneous differentiation 
patterns of individual CD8+ T cells. Science 340, 635–639. 
Gerriets, V.A., Kishton, R.J., Nichols, A.G., Macintyre, A.N., Inoue, M., Ilkayeva, O., 
Winter, P.S., Liu, X., Priyadharshini, B., Slawinska, M.E., et al. (2015). Metabolic 
programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 
125, 194–207. 
Gérard, A., Khan, O., Beemiller, P., Oswald, E., Hu, J., Matloubian, M., and Krummel, 
M.F. (2013). Secondary T cell-T cell synaptic interactions drive the differentiation of 
protective CD8+ T cells. Nat Immunol 14, 356–363. 
Goldstein, B., and Macara, I.G. (2007). The PAR proteins: fundamental players in 
animal cell polarization. Dev. Cell 13, 609–622. 
Grajales-Reyes, G.E., Iwata, A., Albring, J., Wu, X., Tussiwand, R., Kc, W., Kretzer, 
N.M., Briseño, C.G., Durai, V., Bagadia, P., et al. (2015). Batf3 maintains autoactivation 
of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor. Nat 
Immunol 16, 708–717. 
Green, D.R., Galluzzi, L., and Kroemer, G. (2011). Mitochondria and the autophagy-
inflammation-cell death axis in organismal aging. Science 333, 1109–1112. 
Guo, S., Liang, Y., Murphy, S.F., Huang, A., Shen, H., Kelly, D.F., Sobrado, P., and 
Sheng, Z. (2015). A rapid and high content assay that measures cyto-ID-stained 
autophagic compartments and estimates autophagy flux with potential clinical 
applications. Autophagy 11, 560–572. 
Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., 
Turk, B.E., and Shaw, R.J. (2008). AMPK phosphorylation of raptor mediates a 
metabolic checkpoint. Mol. Cell 30, 214–226. 
Habib, S.J., Chen, B.-C., Tsai, F.-C., Anastassiadis, K., Meyer, T., Betzig, E., and 
Nusse, R. (2013). A localized Wnt signal orients asymmetric stem cell division in vitro. 
Science 339, 1445–1448. 
 108 
Hawkins, E.D., Oliaro, J., Kallies, A., Belz, G.T., Filby, A., Hogan, T., Haynes, N., 
Ramsbottom, K.M., Van Ham, V., Kinwell, T., et al. (2013). Regulation of asymmetric 
cell division and polarity by Scribble is not required for humoral immunity. Nat Commun 
4, 1801. 
Hildner, K., Edelson, B.T., Purtha, W.E., Diamond, M., Matsushita, H., Kohyama, M., 
Calderon, B., Schraml, B.U., Unanue, E.R., Diamond, M.S., et al. (2008). Batf3 
deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell 
immunity. Science 322, 1097–1100. 
Ho, T.T., Warr, M.R., Adelman, E.R., Lansinger, O.M., Flach, J., Verovskaya, E.V., 
Figueroa, M.E., and Passegué, E. (2017). Autophagy maintains the metabolism and 
function of young and old stem cells. Nature 543, 205–210. 
Hoppe, P.S., Schwarzfischer, M., Loeffler, D., Kokkaliaris, K.D., Hilsenbeck, O., Moritz, 
N., Endele, M., Filipczyk, A., Gambardella, A., Ahmed, N., et al. (2016). Early myeloid 
lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Nature 535, 
299–302. 
Huber, M., and Lohoff, M. (2014). IRF4 at the crossroads of effector T-cell fate decision. 
Eur. J. Immunol. 44, 1886–1895. 
Inoki, K., Zhu, T., and Guan, K.-L. (2003). TSC2 mediates cellular energy response to 
control cell growth and survival. Cell 115, 577–590. 
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D.E., Schafer, Z.T., Evans, 
R.M., Suda, T., Lee, C.-H., et al. (2012). A PML–PPAR-δ pathway for fatty acid 
oxidation regulates hematopoietic stem cell maintenance. Nat. Med. 18, 1350–1358. 
Ito, K., and Ito, K. (2016). Metabolism and the Control of Cell Fate Decisions and Stem 
Cell Renewal. Annu. Rev. Cell Dev. Biol. 32, 399–409. 
Ito, K., Turcotte, R., Cui, J., Zimmerman, S.E., Pinho, S., Mizoguchi, T., Arai, F., 
Runnels, J.M., Alt, C., Teruya-Feldstein, J., et al. (2016). Self-renewal of a purified 
Tie2+ hematopoietic stem cell population relies on mitochondrial clearance. Science 
354, 1156–1160. 
Jang, K.-J., Mano, H., Aoki, K., Hayashi, T., Muto, A., Nambu, Y., Takahashi, K., Itoh, 
K., Taketani, S., Nutt, S.L., et al. (2015). Mitochondrial function provides instructive 
signals for activation-induced B-cell fates. Nat Commun 6, 6750. 
Jørgensen, S.B., Viollet, B., Andreelli, F., Frøsig, C., Birk, J.B., Schjerling, P., Vaulont, 
S., Richter, E.A., and Wojtaszewski, J.F.P. (2004). Knockout of the alpha2 but not 
alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-
carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in 
skeletal muscle. J. Biol. Chem. 279, 1070–1079. 
Kaech, S.M., and Ahmed, R. (2001). Memory CD8+ T cell differentiation: initial antigen 
 109 
encounter triggers a developmental program in naïve cells. Nat Immunol 2, 415–422. 
Katajisto, P., Döhla, J., Chaffer, C.L., Pentinmikko, N., Marjanovic, N., Iqbal, S., Zoncu, 
R., Chen, W., Weinberg, R.A., and Sabatini, D.M. (2015). Asymmetric apportioning of 
aged mitochondria between daughter cells is required for stemness. Science 348, 340–
343. 
Keppler, S.J., Gasparrini, F., Burbage, M., Aggarwal, S., Frederico, B., Geha, R.S., 
Way, M., Bruckbauer, A., and Batista, F.D. (2015). Wiskott-Aldrich Syndrome 
Interacting Protein Deficiency Uncovers the Role of the Co-receptor CD19 as a Generic 
Hub for PI3 Kinase Signaling in B Cells. Immunity 43, 660–673. 
Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., 
and Dalla-Favera, R. (2006). Transcription factor IRF4 controls plasma cell 
differentiation and class-switch recombination. Nat Immunol 7, 773–782. 
Kurotaki, D., Yamamoto, M., Nishiyama, A., Uno, K., Ban, T., Ichino, M., Sasaki, H., 
Matsunaga, S., Yoshinari, M., Ryo, A., et al. (2014). IRF8 inhibits C/EBPα activity to 
restrain mononuclear phagocyte progenitors from differentiating into neutrophils. Nat 
Commun 5, 4978. 
Le Floc'h, A., Tanaka, Y., Bantilan, N.S., Voisinne, G., Altan-Bonnet, G., Fukui, Y., and 
Huse, M. (2013). Annular PIP3 accumulation controls actin architecture and modulates 
cytotoxicity at the immunological synapse. Journal of Experimental Medicine 210, 2721–
2737. 
Lee, J., Zhou, Y.J., Ma, W., Zhang, W., Aljoufi, A., Luh, T., Lucero, K., Liang, D., 
Thomsen, M., Bhagat, G., et al. (2017). Lineage specification of human dendritic cells is 
marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors. 
Nat Immunol 18, 877–888. 
Lin, W.-H.W., Adams, W.C., Nish, S.A., Chen, Y.-H., Bonnie, Y., Rothman, N.J., 
Kratchmarov, R., Okada, T., Klein, U., and Reiner, S.L. (2015). Asymmetric PI3K 
Signaling Driving Developmental and Regenerative Cell Fate Bifurcation. Cell Reports 
13, 2203–2218. 
Lin, W.-H.W., Nish, S.A., Bonnie, Y., Chen, Y.-H., Adams, W.C., Kratchmarov, R., 
Rothman, N.J., Bhandoola, A., Xue, H.-H., and Reiner, S.L. (2016). CD8(+) T 
Lymphocyte Self-Renewal during Effector Cell Determination. Cell Reports 17, 1773–
1782. 
Liu, K., Victora, G.D., Schwickert, T.A., Guermonprez, P., Meredith, M.M., Yao, K., Chu, 
F.-F., Randolph, G.J., Rudensky, A.Y., and Nussenzweig, M. (2009). In vivo analysis of 
dendritic cell development and homeostasis. Science 324, 392–397. 
Lohoff, M., Mittrücker, H.-W., Brüstle, A., Sommer, F., Casper, B., Huber, M., Ferrick, 
D.A., Duncan, G.S., and Mak, T.W. (2004). Enhanced TCR-induced apoptosis in 
interferon regulatory factor 4-deficient CD4(+) Th cells. J. Exp. Med. 200, 247–253. 
 110 
Lohoff, M., Mittrücker, H.-W., Prechtl, S., Bischof, S., Sommer, F., Kock, S., Ferrick, 
D.A., Duncan, G.S., Gessner, A., and Mak, T.W. (2002). Dysregulated T helper cell 
differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. 
U.S.a. 99, 11808–11812. 
Lucas, C.L., Chandra, A., Nejentsev, S., Condliffe, A.M., and Okkenhaug, K. (2016). 
PI3Kδ and primary immunodeficiencies. Nat Rev Immunol 16, 702–714. 
Luchsinger, L.L., de Almeida, M.J., Corrigan, D.J., Mumau, M., and Snoeck, H.-W. 
(2016). Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid 
potential. Nature 529, 528–531. 
Macintyre, A.N., Gerriets, V.A., Nichols, A.G., Michalek, R.D., Rudolph, M.C., 
Deoliveira, D., Anderson, S.M., Abel, E.D., Chen, B.J., Hale, L.P., et al. (2014). The 
glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector 
function. Cell Metab. 20, 61–72. 
Mahnke, J., Schumacher, V., Ahrens, S., Käding, N., Feldhoff, L.M., Huber, M., Rupp, 
J., Raczkowski, F., and Mittrücker, H.-W. (2016). Interferon Regulatory Factor 4 controls 
TH1 cell effector function and metabolism. Sci Rep 6, 35521. 
Man, K., Miasari, M., Shi, W., Xin, A., Henstridge, D.C., Preston, S., Pellegrini, M., Belz, 
G.T., Smyth, G.K., Febbraio, M.A., et al. (2013). The transcription factor IRF4 is 
essential for TCR affinity-mediated metabolic programming and clonal expansion of T 
cells. Nat Immunol 14, 1155–1165. 
Marat, A.L., and Haucke, V. (2016). Phosphatidylinositol 3-phosphates-at the interface 
between cell signalling and membrane traffic. Embo J. 35, 561–579. 
Masopust, D., Vezys, V., Marzo, A.L., and Lefrançois, L. (2001). Preferential localization 
of effector memory cells in nonlymphoid tissue. Science 291, 2413–2417. 
Metz, P.J., Arsenio, J., Kakaradov, B., Kim, S.H., Remedios, K.A., Oakley, K., Akimoto, 
K., Ohno, S., Yeo, G.W., and Chang, J.T. (2015). Regulation of Asymmetric Division 
and CD8+ T Lymphocyte Fate Specification by Protein Kinase Cζ and Protein Kinase 
Cλ/ι. J. Immunol. 194, 2249–2259. 
Metz, P.J., Lopez, J., Kim, S.H., Akimoto, K., Ohno, S., and Chang, J.T. (2016). 
Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early 
Specification of CD8(+) T Lymphocyte Fates. Sci Rep 6, 19182. 
Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, 
E.F., Sullivan, S.A., Nichols, A.G., and Rathmell, J.C. (2011). Cutting edge: distinct 
glycolytic and lipid oxidative metabolic programs are essential for effector and 
regulatory CD4+ T cell subsets. J. Immunol. 186, 3299–3303. 
Mishra, P., and Chan, D.C. (2014). Mitochondrial dynamics and inheritance during cell 
division, development and disease. Nat. Rev. Mol. Cell Biol. 15, 634–646. 
 111 
Morrison, S.J., and Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in 
development and cancer. Nature 441, 1068–1074. 
Murphy, T.L., Grajales-Reyes, G.E., Wu, X., Tussiwand, R., Briseño, C.G., Iwata, A., 
Kretzer, N.M., Durai, V., and Murphy, K.M. (2016). Transcriptional Control of Dendritic 
Cell Development. Annu. Rev. Immunol. 34, 93–119. 
Naik, S.H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O'Keeffe, M., and 
Shortman, K. (2006). Intrasplenic steady-state dendritic cell precursors that are distinct 
from monocytes. Nat Immunol 7, 663–671. 
Naik, S.H., Perié, L., Swart, E., Gerlach, C., van Rooij, N., de Boer, R.J., and 
Schumacher, T.N. (2013). Diverse and heritable lineage imprinting of early 
haematopoietic progenitors. Nature 496, 229–232. 
Naik, S.H., Proietto, A.I., Wilson, N.S., Dakic, A., Schnorrer, P., Fuchsberger, M., 
Lahoud, M.H., O'Keeffe, M., Shao, Q.-X., Chen, W.-F., et al. (2005). Cutting edge: 
generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine 
kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592–6597. 
Nakada, D., Saunders, T.L., and Morrison, S.J. (2010). Lkb1 regulates cell cycle and 
energy metabolism in haematopoietic stem cells. Nature 468, 653–658. 
Nish, S.A., Lin, W.-H.W., and Reiner, S.L. (2017a). Lymphocyte Fate and Metabolism: A 
Clonal Balancing Act. Trends in Cell Biology 27, 946–954. 
Nish, S.A., Zens, K.D., Kratchmarov, R., Lin, W.-H.W., Adams, W.C., Chen, Y.-H., 
Bonnie, Y., Rothman, N.J., Bhandoola, A., Xue, H.-H., et al. (2017b). CD4+ T cell 
effector commitment coupled to self-renewal by asymmetric cell divisions. Journal of 
Experimental Medicine 214, 39–47. 
Nobs, S.P., Schneider, C., Dietrich, M.G., Brocker, T., Rolink, A., Hirsch, E., and Kopf, 
M. (2015). PI3-Kinase-γ Has a Distinct and Essential Role in Lung-Specific Dendritic 
Cell Development. Immunity 43, 674–689. 
O'Sullivan, D., van der Windt, G.J.W., Huang, S.C.-C., Curtis, J.D., Chang, C.-H., Buck, 
M.D., Qiu, J., Smith, A.M., Lam, W.Y., DiPlato, L.M., et al. (2014). Memory CD8(+) T 
cells use cell-intrinsic lipolysis to support the metabolic programming necessary for 
development. Immunity 41, 75–88. 
O'Sullivan, T.E., Johnson, L.R., Kang, H.H., and Sun, J.C. (2015). BNIP3- and BNIP3L-
Mediated Mitophagy Promotes the Generation of Natural Killer Cell Memory. Immunity 
43, 331–342. 
Owusu-Ansah, E., and Banerjee, U. (2009). Reactive oxygen species prime Drosophila 
haematopoietic progenitors for differentiation. Nature 461, 537–541. 
Pang, W.W., Price, E.A., Sahoo, D., Beerman, I., Maloney, W.J., Rossi, D.J., Schrier, 
 112 
S.L., and Weissman, I.L. (2011). Human bone marrow hematopoietic stem cells are 
increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. U.S.a. 108, 
20012–20017. 
Pearce, E.L., Walsh, M.C., Cejas, P.J., Harms, G.M., Shen, H., Wang, L.-S., Jones, 
R.G., and Choi, Y. (2009). Enhancing CD8 T-cell memory by modulating fatty acid 
metabolism. Nature 460, 103–107. 
Pedicord, V.A., Cross, J.R., Montalvo-Ortiz, W., Miller, M.L., and Allison, J.P. (2015). 
Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell 
priming to promote memory formation and metabolic readiness. J. Immunol. 194, 2089–
2098. 
Pei, W., Feyerabend, T.B., Rössler, J., Wang, X., Postrach, D., Busch, K., Rode, I., 
Klapproth, K., Dietlein, N., Quedenau, C., et al. (2017). Polylox barcoding reveals 
haematopoietic stem cell fates realized in vivo. Nature 548, 456–460. 
Pham, K., Shimoni, R., Charnley, M., Ludford-Menting, M.J., Hawkins, E.D., 
Ramsbottom, K., Oliaro, J., Izon, D., Ting, S.B., Reynolds, J., et al. (2015). Asymmetric 
cell division during T cell development controls downstream fate. The Journal of Cell 
Biology 210, 933–950. 
Pollizzi, K.N., and Powell, J.D. (2014). Integrating canonical and metabolic signalling 
programmes in the regulation of T cell responses. Nat Rev Immunol 14, 435–446. 
Pollizzi, K.N., Sun, I.-H., Patel, C.H., Lo, Y.-C., Oh, M.-H., Waickman, A.T., Tam, A.J., 
Blosser, R.L., Wen, J., Delgoffe, G.M., et al. (2016). Asymmetric inheritance of 
mTORC1 kinase activity during division dictates CD8(+) T cell differentiation. Nat 
Immunol 17, 704–711. 
Powell, J.D., Lerner, C.G., and Schwartz, R.H. (1999). Inhibition of cell cycle 
progression by rapamycin induces T cell clonal anergy even in the presence of 
costimulation. J. Immunol. 162, 2775–2784. 
Ray, J.P., Staron, M.M., Shyer, J.A., Ho, P.-C., Marshall, H.D., Gray, S.M., Laidlaw, 
B.J., Araki, K., Ahmed, R., Kaech, S.M., et al. (2015). The Interleukin-2-mTORc1 Kinase 
Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular 
B Helper T Cells. Immunity 43, 690–702. 
Reiner, S.L., and Adams, W.C. (2014). Lymphocyte fate specification as a deterministic 
but highly plastic process. Nat Rev Immunol 14, 699–704. 
Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T., and Jenkins, M.K. (2001). Visualizing 
the generation of memory CD4 T cells in the whole body. Nature 410, 101–105. 
Rimmelé, P., Liang, R., Bigarella, C.L., Kocabas, F., Xie, J., Serasinghe, M.N., Chipuk, 
J., Sadek, H., Zhang, C.C., and Ghaffari, S. (2015). Mitochondrial metabolism in 
hematopoietic stem cells requires functional FOXO3. EMBO Rep. 16, 1164–1176. 
 113 
Sallusto, F., Geginat, J., and Lanzavecchia, A. (2004). Central memory and effector 
memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 
22, 745–763. 
Sathaliyawala, T., O'Gorman, W.E., Greter, M., Bogunovic, M., Konjufca, V., Hou, Z.E., 
Nolan, G.P., Miller, M.J., Merad, M., and Reizis, B. (2010). Mammalian target of 
rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. 
Immunity 33, 597–606. 
Scheffler, J.M., Sparber, F., Tripp, C.H., Herrmann, C., Humenberger, A., Blitz, J., 
Romani, N., Stoitzner, P., and Huber, L.A. (2014). LAMTOR2 regulates dendritic cell 
homeostasis through FLT3-dependent mTOR signalling. Nat Commun 5, 5138. 
Schlitzer, A., Sivakamasundari, V., Chen, J., Sumatoh, H.R.B., Schreuder, J., Lum, J., 
Malleret, B., Zhang, S., Larbi, A., Zolezzi, F., et al. (2015). Identification of cDC1- and 
cDC2-committed DC progenitors reveals early lineage priming at the common DC 
progenitor stage in the bone marrow. Nat Immunol 16, 718–728. 
Schweighoffer, E., Nys, J., Vanes, L., Smithers, N., and Tybulewicz, V.L.J. (2017). 
TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. 
Journal of Experimental Medicine 214, 1269–1280. 
Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A., Wang, C.-
R., Schumacker, P.T., Licht, J.D., Perlman, H., et al. (2013). Mitochondria are required 
for antigen-specific T cell activation through reactive oxygen species signaling. 
Immunity 38, 225–236. 
Sengupta, A., Duran, A., Ishikawa, E., Florian, M.C., Dunn, S.K., Ficker, A.M., Leitges, 
M., Geiger, H., Diaz-Meco, M., Moscat, J., et al. (2011). Atypical protein kinase C 
(aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell 
activity and blood formation. Proc. Natl. Acad. Sci. U.S.a. 108, 9957–9962. 
Severinson, E., and Westerberg, L. (2003). Regulation of adhesion and motility in B 
lymphocytes. Scand. J. Immunol. 58, 139–144. 
Sezgin, E., Levental, I., Mayor, S., and Eggeling, C. (2017). The mystery of membrane 
organization: composition, regulation and roles of lipid rafts. Nat. Rev. Mol. Cell Biol. 18, 
361–374. 
Sichien, D., Scott, C.L., Martens, L., Vanderkerken, M., Van Gassen, S., Plantinga, M., 
Joeris, T., De Prijck, S., Vanhoutte, L., Vanheerswynghels, M., et al. (2016). IRF8 
Transcription Factor Controls Survival and Function of Terminally Differentiated 
Conventional and Plasmacytoid Dendritic Cells, Respectively. Immunity 45, 626–640. 
Sinclair, C., Bommakanti, G., Gardinassi, L., Loebbermann, J., Johnson, M.J., 
Hakimpour, P., Hagan, T., Benitez, L., Todor, A., Machiah, D., et al. (2017). mTOR 
regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic 
inflammation. Science 357, 1014–1021. 
 114 
Sinclair, L.V., Rolf, J., Emslie, E., Shi, Y.-B., Taylor, P.M., and Cantrell, D.A. (2013). 
Control of amino-acid transport by antigen receptors coordinates the metabolic 
reprogramming essential for T cell differentiation. Nat Immunol 14, 500–508. 
Snoeck, H.-W. (2013). Aging of the hematopoietic system. Curr. Opin. Hematol. 20, 
355–361. 
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., 
Hoffmann, M., Ulges, A., Taube, C., et al. (2010). Interferon-regulatory factor 4 is 
essential for the developmental program of T helper 9 cells. Immunity 33, 192–202. 
Taylor, J.J., Pape, K.A., Steach, H.R., and Jenkins, M.K. (2015). Apoptosis and antigen 
affinity limit effector cell differentiation of a single naïve B cell. Science 347, 784–787. 
Thaunat, O., Granja, A.G., Barral, P., Filby, A., Montaner, B., Collinson, L., Martinez-
Martin, N., Harwood, N.E., Bruckbauer, A., and Batista, F.D. (2012). Asymmetric 
segregation of polarized antigen on B cell division shapes presentation capacity. 
Science 335, 475–479. 
Ting, S.B., Deneault, E., Hope, K., Cellot, S., Chagraoui, J., Mayotte, N., Dorn, J.F., 
Laverdure, J.-P., Harvey, M., Hawkins, E.D., et al. (2012). Asymmetric segregation and 
self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2. Blood 
119, 2510–2522. 
Tominaga, N., Ohkusu-Tsukada, K., Udono, H., Abe, R., Matsuyama, T., and Yui, K. 
(2003). Development of Th1 and not Th2 immune responses in mice lacking IFN-
regulatory factor-4. Int. Immunol. 15, 1–10. 
Tubo, N.J., Pagán, A.J., Taylor, J.J., Nelson, R.W., Linehan, J.L., Ertelt, J.M., Huseby, 
E.S., Way, S.S., and Jenkins, M.K. (2013). Single Naive CD4(+) T Cells from a Diverse 
Repertoire Produce Different Effector Cell Types during Infection. Cell 153, 785–796. 
Tussiwand, R., Everts, B., Grajales-Reyes, G.E., Kretzer, N.M., Iwata, A., Bagaitkar, J., 
Wu, X., Wong, R., Anderson, D.A., Murphy, T.L., et al. (2015). Klf4 expression in 
conventional dendritic cells is required for T helper 2 cell responses. Immunity 42, 916–
928. 
van der Windt, G.J.W., O'Sullivan, D., Everts, B., Huang, S.C.-C., Buck, M.D., Curtis, 
J.D., Chang, C.-H., Smith, A.M., Ai, T., Faubert, B., et al. (2013). CD8 memory T cells 
have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. 
Sci. U.S.a. 110, 14336–14341. 
Vander Lugt, B., Khan, A.A., Hackney, J.A., Agrawal, S., Lesch, J., Zhou, M., Lee, W.P., 
Park, S., Xu, M., DeVoss, J., et al. (2014). Transcriptional programming of dendritic 
cells for enhanced MHC class II antigen presentation. Nat Immunol 15, 161–167. 
Verbist, K.C., Guy, C.S., Milasta, S., Liedmann, S., Kamiński, M.M., Wang, R., and 
Green, D.R. (2016). Metabolic maintenance of cell asymmetry following division in 
 115 
activated T lymphocytes. Nature 532, 389–393. 
Wang, D., Wang, J., Bonamy, G.M.C., Meeusen, S., Brusch, R.G., Turk, C., Yang, P., 
and Schultz, P.G. (2012). A small molecule promotes mitochondrial fusion in 
mammalian cells. Angew. Chem. Int. Ed. Engl. 51, 9302–9305. 
Wang, H., Yan, M., Sun, J., Jain, S., Yoshimi, R., Abolfath, S.M., Ozato, K., Coleman, 
W.G., Ng, A.P., Metcalf, D., et al. (2014). A reporter mouse reveals lineage-specific and 
heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation. J. 
Immunol. 193, 1766–1777. 
Wang, Y., Huang, G., Zeng, H., Yang, K., Lamb, R.F., and Chi, H. (2013). Tuberous 
sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic 
cells. Proc. Natl. Acad. Sci. U.S.a. 110, E4894–E4903. 
Wieman, H.L., Wofford, J.A., and Rathmell, J.C. (2007). Cytokine stimulation promotes 
glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and 
trafficking. Mol. Biol. Cell 18, 1437–1446. 
Willinger, T., Ferguson, S.M., Pereira, J.P., De Camilli, P., and Flavell, R.A. (2014). 
Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling. Journal of 
Experimental Medicine 211, 685–700. 
Wofford, J.A., Wieman, H.L., Jacobs, S.R., Zhao, Y., and Rathmell, J.C. (2008). IL-7 
promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to 
support T-cell survival. Blood 111, 2101–2111. 
Wu, M., Kwon, H.Y., Rattis, F., Blum, J., Zhao, C., Ashkenazi, R., Jackson, T.L., 
Gaiano, N., Oliver, T., and Reya, T. (2007). Imaging hematopoietic precursor division in 
real time. Cell Stem Cell 1, 541–554. 
Wu, T., Shin, H.M., Moseman, E.A., Ji, Y., Huang, B., Harly, C., Sen, J.M., Berg, L.J., 
Gattinoni, L., McGavern, D.B., et al. (2015). TCF1 Is Required for the T Follicular Helper 
Cell Response to Viral Infection. Cell Reports 12, 2099–2110. 
Xu, H., Chaudhri, V.K., Wu, Z., Biliouris, K., Dienger-Stambaugh, K., Rochman, Y., and 
Singh, H. (2015a). Regulation of bifurcating B cell trajectories by mutual antagonism 
between transcription factors IRF4 and IRF8. Nat Immunol 16, 1274–1281. 
Xu, L., Cao, Y., Xie, Z., Huang, Q., Bai, Q., Yang, X., He, R., Hao, Y., Wang, H., Zhao, 
T., et al. (2015b). The transcription factor TCF-1 initiates the differentiation of T(FH) 
cells during acute viral infection. Nat Immunol 16, 991–999. 
Xu, X., Araki, K., Li, S., Han, J.-H., Ye, L., Tan, W.G., Konieczny, B.T., Bruinsma, M.W., 
Martinez, J., Pearce, E.L., et al. (2014). Autophagy is essential for effector CD8(+) T cell 
survival and memory formation. Nat Immunol 15, 1152–1161. 
Yalcin, S., Marinkovic, D., Mungamuri, S.K., Zhang, X., Tong, W., Sellers, R., and 
 116 
Ghaffari, S. (2010). ROS-mediated amplification of AKT/mTOR signalling pathway leads 
to myeloproliferative syndrome in Foxo3(-/-) mice. Embo J. 29, 4118–4131. 
Yao, S., Buzo, B.F., Pham, D., Jiang, L., Taparowsky, E.J., Kaplan, M.H., and Sun, J. 
(2013). Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector 
differentiation. Immunity 39, 833–845. 
Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J.M., Chu, T.-T., Corcoran, L., 
Treuting, P., Klein, U., and Rudensky, A.Y. (2009). Regulatory T-cell suppressor 
program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351–
356. 
Zhou, X., and Xue, H.-H. (2012). Cutting edge: generation of memory precursors and 
functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-
binding factor-1. J. Immunol. 189, 2722–2726. 
Zhu, J., Yamane, H., and Paul, W.E. (2010). Differentiation of effector CD4 T cell 
populations. Annu. Rev. Immunol. 28, 445–489. 
Zimdahl, B., Ito, T., Blevins, A., Bajaj, J., Konuma, T., Weeks, J., Koechlein, C.S., 
Kwon, H.Y., Arami, O., Rizzieri, D., et al. (2014). Lis1 regulates asymmetric division in 
hematopoietic stem cells and in leukemia. Nat. Genet. 46, 245–252. 
 
